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Abstract 
Background: Mental diagnoses have become the most common disability pension (DP) 
diagnoses in OECD countries. Up to half of DP due to mental diagnoses are due to common 
mental disorders (CMDs). So far, research has mainly focused on risk factors of DP rather 
than on the future life situation of people with DP. Nevertheless, the latter types of studies 
suggest higher mortality, including suicide among DP recipients. Therefore, knowledge on 
morbidity and suicidal behaviour following DP is needed. Investigations of the associations 
between DP and adverse mental health outcomes should be multifaceted, considering socio-
demographics, co-morbidity, existing regulations about DP benefit, medical factors, i.e., 
healthcare use and prescribed medication, etc. The thesis aimed to gain knowledge about the 
association of DP due to CMD with subsequent psychiatric morbidity and suicidal behaviour 
in the general population of Sweden. Methods: In study I and II all individuals who were on 
DP due to CMD throughout 2005 were included. Cox regression analyses calculating hazard 
ratios (HRs) were conducted for measuring the associations between socio-demographics, 
specialized healthcare use, medication, and measures of DP with suicidal behaviour during a 
5-year follow-up. In study II, all analyses were stratified by sex and age. In study III, 
Generalized Estimating Equations (GEE) were applied to identify the trajectories of 
specialized healthcare use before and after granted DP during a 7-year period in cohorts with 
DP due to CMD, granted either in 2005-06 or in 2009-10. The latter cohort also comprised 
the study population for study IV. In study IV, a group-based trajectory method was used to 
identify different trajectory groups according to the amount of defined daily doses of 
prescribed antidepressants (AD) during 6 years of observation. Information on socio-
demographics, DP, specialized healthcare use, medication, and death was derived from five 
nationwide registers. Data were linked at individual level by unique identification numbers. 
Results: In the disability pensioners, sex, age, education level, family situation, previous in- 
or specialized outpatient care due to mental diagnoses or suicide attempt, and medication 
were strongly associated with subsequent suicidal behaviour (HR range: 1.15-3.89) (study I). 
Among the DP measures, stress-related mental disorders as main DP diagnosis, compared to 
depressive disorders were associated with a lower risk for subsequent suicidal behaviour (HR 
range: 0.4-0.7). Among other measures, psychiatric comorbidity, and full-time DP were 
associated with a higher risk of subsequent suicidal behaviour (HR range: 1.3-3.3) compared 
to no comorbidity and part-time DP, respectively (study II). Moreover, healthcare use due to 
mental diagnoses increased until the year preceding DP and declined thereafter (study III). 
After the introduction of stricter DP granting criteria, people had higher levels of such 
healthcare preceding DP, nevertheless, still less than half of the individuals received 
specialized mental healthcare a year prior to granted DP. Analyses also showed a steeper 
decline in healthcare use due to mental diagnoses immediately following DP among 
individuals granted DP with stricter criteria (study III). Among the disability pensioners, five 
trajectory groups were identified according to the annual amount of prescribed ADs. The 
groups differed particularly regarding age, main DP diagnosis, and previous healthcare use. 
Moreover, many had a very low dose of AD before granted DP, and for most of them, there 
was hardly any decline in the AD trajectories following granted DP (study IV). Conclusion: 
Important aspects to consider for subsequent psychiatric morbidity and suicidal behaviour in 
individuals after granted DP due to CMD should include, socio-demographics, the main and 
secondary DP diagnoses, grade of DP, and diagnosis specific previous specialized healthcare 
use. The frequency of healthcare use was lower immediately following DP, but the amount of 
prescribed ADs did not alter for most of the disability pensioners in that period. Both DP 
granting and subsequent mental health appears to be associated with the DP granting 
regulations. Importantly, the low frequency of specialized mental healthcare use and amount 
of prescribed ADs during the pre-DP period may indicate a sub-optimal treatment before the 
premature labour market exit among individuals granted DP due to CMD.  
Sammanfattning 
 
Bakgrund: Psykiska diagnoser har blivit den vanligaste anledningen till att individer beviljas 
sjuk-och aktivitetsersättning (SA), tidigare förtidspension, i OECD-länder. Närmare hälften 
av alla personer som beviljats SA i psykiska diagnoser har diagnoser relaterade till 
depression, ångest- eller stressrelaterade syndrom. Hittills har forskningen framförallt 
fokuserat på riskfaktorer för att beviljas SA snarare än på den framtida livssituationen för 
personer med SA. De få studier som finns om framtida situation visar bl.a. på en högre 
mortalitet, inkluderande självmord, bland personer med SA. Mer kunskap behövs därför om 
risk för framtida morbiditet och suicidalt beteende bland personer som beviljats SA. Sådana 
studier behöver bl.a. ta hänsyn till sociodemografiska faktorer, samsjuklighet, regelverk, 
sjukvård och medicinering. Syftet med denna avhandling var att studera sambanden mellan 
att ha SA i depression, ångest- och stressrelaterade syndrom och framtida psykisk sjuklighet 
och suicidalt beteende i Sverige. Metod: Fyra delstudier gjordes, baserade på länkade 
individdata angående sociodemografiska faktorer, SA, specialiserad sjukvård, medicinering 
och död från fem olika rikstäckande register. I studie I och II inkluderades alla personer som 
bodde i Sverige under 2005 och som beviljats SA i depression, ångest- och stressrelaterade 
syndrom. Samband mellan sociodemografiska faktorer, specialiserad sjukvård, medicinering 
och suicidalt beteende under de följande fem åren beräknades med hjälp av Cox 
regressionsanalyser. I Studie II stratifierades de analyserna för kön och ålder. I studie III 
identifierades mönster av användning av specialiserad sjukvård under en 7-årsperiod före och 
efter beviljad SA i depression ångest- och stressrelaterade syndrom i två kohorter - de som 
fick SA antingen under 2005-06 eller under 2009-10 - med hjälp av Generalized Estimating 
Equations (GEE) (i juli 2008 infördes striktare regler för beviljande av SA). Den senare 
kohorten studerades även i studie IV beträffande mönster för användning av receptbelagda 
antidepressiva läkemedel under en 6-års period. Resultat: Bland personer med SA i 
depression, ångest- och stressrelaterade syndrom hade kön, ålder, utbildningsnivå, 
familjesituation, specialiserad sjukvård för psykiatriska diagnoser och medicinering samband 
med framtida suicidalt beteende (hazard ratios, HRs: 1.15–3.89, studie I). De som hade SA i 
stressrelaterade syndrom hade lägre risk för framtida suicidalt beteende jämfört med de med 
depression (HRs: 0.4–0.7). Psykisk samsjuklighet och SA på heltid hade samband med högre 
risk för framtida suicidalt beteende (HRs: 1.3–3.3) jämfört med ingen samsjuklighet och SA 
på deltid (studie II). Specialiserad öppen- eller slutenvård för psykiatriska diagnoser ökade 
före beviljandet av SA och minskade därefter (studie III). Efter att striktare regler 
introducerades för SA beviljades betydligt färre personer SA i depression, ångest- och 
stressrelaterade syndrom och en större andel av dem som beviljades SA i dessa diagnoser 
hade psykiatrisk specialistsjukvård innan beviljandet. Trots detta hade färre än hälften fått 
sådan psykiatrisk specialistvård under året före beviljandet av SA. Andelen med psykiatrisk 
specialistsjukvård efter beviljandet av SA minskade kraftigare efter att striktare regler för SA 
införts (studie III). Fem olika mönster för användning av antidepressiva läkemedel kunde 
identifieras bland personer med SA. Dessa grupper skiljde sig åt framförallt med avseende på 
ålder, SA diagnos samt tidigare specialistsjukvård. Dessutom hade många väldigt låga doser 
av antidepressiva läkemedel före beviljandet av SA och för de flesta personerna minskade 
inte sådan medicinering efter att ha fått SA (studie IV). Slutsatser: Faktorer som kan ha 
betydelse för framtida psykisk sjuklighet och suicidalt beteende bland personer med SA i 
depression, ångest- eller stressrelaterade syndrom är såväl sociodemografiska faktorer som 
typ av huvuddiagnos, omfattning av SA (hel- eller deltid) och tidigare typ av specialistvård. 
Nyttjandet av specialiserad sjukvård var lägre direkt efter beviljandet av SA däremot inte 
receptbelagd antidepressiv medicinering. Både beviljande av SA och framtida psykisk hälsa 
verkar ha samband med regler för SA. Det är viktigt att poängtera att den låga förekomsten av 
psykiatrisk specialistvård och låga dygnsdoser av antidepressiva medel före beviljandet av 
SA kan tyda på en mindre optimal behandling innan beviljandet av SA.  
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1 Introduction 
A disease or injury may lead not only to limitation of function of an individual but also to 
one’s work incapacity, and that individual might be entitled to sickness absence or disability 
pension benefit, here called work incapacity [1-3]. If such work incapacity was merely a 
socio-economic, biomedical, or political matter in the past, it is now perceived as a public 
health problem in many of the member states of the Organization for Economic Co-operation 
and Development (OECD) countries [2, 4-6]. 
Work incapacity can be influenced, among others, by psychological, social, administrative, or 
cultural aspects. Work incapacity, may lead to temporal (i.e., sickness absence) or permanent 
(i.e., disability pension) exclusion from the labour market. This thesis is focused on disability 
pension (DP). There are some other similar English terms, expressing more or less the 
permanent exit from the labour market due to work incapacity caused by disease or injury, of 
which the following are widely used: disability benefit [7], incapacity benefit [8], disability 
retirement [9], ill-health retirement [10, 11], permanent workplace disability [12], work 
disability pension [13], pension on medical ground, health-related early retirement [14] etc. 
Despite the fact that the prevalence of DP across the OECD countries seems to be stable for 
the last few years, at around six percent, yet since early 2000s there is a remarkable increase 
in the incidence of mental DP diagnoses, especially in DP due to common mental disorders 
(CMDs), e.g., depression, anxiety, and stress-related mental disorders [3, 5, 6, 15-19]. In 
Sweden, these increases were especially high in young adults. From 1995 to 2015 the yearly 
incidence of DP in individuals below 30 years of age increased for more than four-fold, from 
1931 to 8400 [3]. In Sweden, the incidence of DP due to mental diagnoses doubled in only 
ten years, from 25% to 51% from 2000 to 2010 [3]. This development implies high costs for 
society, possible shortage of labour, and for the people on DP possible different types of 
economic, social and health outcomes. 
Despite the fact that knowledge on the positive and negative outcomes or “side effects” of 
being granted DP is of crucial clinical and public health interest, the scientific literature is 
surprisingly sparse. With regard to long-term outcomes among individuals on DP, the risk of 
all-cause and cause-specific premature death was found to be higher compared to in the 
general population, regardless of the DP diagnoses [20-22]. The scientific knowledge base 
regarding the association of DP with future morbidity and mortality due to mental diagnoses 
is even more limited. Being granted DP seems to involve a higher risk of suicide when 
comparing with the general population not on DP, also when adjusting for hospitalization due 
to mental diagnoses, socio-economic status, and parental risk factors such as parental 
suicidality, DP, and educational level [23-25]. Potential other mechanisms underlying the 
association of DP with subsequent psychiatric morbidity and suicidal behaviour (suicide 
attempt and suicide) may involve life dissatisfaction, unhealthy life styles (high alcohol and 
tobacco use), or co-morbid disorders, as these conditions seem to be related to DP [26-28] 
and may encompass high risk of mental disorders and suicidal behavior after DP. 
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There are also only few studies investigating if transition to DP has an effect on individuals’ 
mental health status. Five recent Scandinavian studies suggest that self-reported symptoms of 
depression and anxiety as well as prescription of antidepressants (ADs) to increase before 
being granted DP, after which a decrease in these measurements was noted [29-33]. Some of 
the mentioned studies, however, suffer from different shortcomings, e.g., data have often 
been derived from selected segments of the work force or from selected regional areas. 
Furthermore, there is a lack of studies investigating if effect sizes in the associations with 
mental health outcomes vary with different subgroups of people granted DP, e.g., related to 
age, sex, DP diagnosis, as well as socio-economic status. Definition of subgroups in the 
analyses would help to improve the specification of potential risk groups regarding the future 
development of the underlying mental disorders as well as suicidal behaviour. Early detection 
of vulnerable individuals might thus be facilitated, and preventive, possibly tailor-made, 
interventions could be started earlier. 
The prevalence and incidence of DP are very complex phenomena, affected by many aspects 
including changes in social insurance regulations [34]. Furthermore, particularly since the 
1990s, several conditions that are potentially relevant for DP prevalence and incidence have 
changed. These factors include temporal changes in unemployment rates, increase in 
psychosocial work stress, reorganizations within the public and private sectors, and 
deteriorating mental well-being particularly among younger persons [35-37]. In order to 
acknowledge these temporal trends affecting incidence and prevalence rates and the profile of 
DP diagnoses, analyses using different cohorts were carried out in this thesis. A recent study 
showed that risk estimates for all-cause mortality were considerably lower in a cohort of 
individuals being granted DP due to mental disorders in 2005 compared to in 1995 [21]. 
These findings have to be interpreted in the light of strong increase in the incidence of DP 
due to mental diagnoses during that period. 
1.1 Disability pension policy across OECD countries 
Social security and insurance systems may differ substantially between countries resulting 
also in different regulations with regard to granting of DP in different countries [2, 5, 38]. In 
general, compensation for disability may be cause-based or disability based [38]. For cause-
based, the coverage is only if the injury or disease is attributable to a specific cause, e.g. work 
related. It generally covers access to medical care and expenses related to accidents and 
occupational diseases directly related to the work place. Here, the definition of occupational 
disease may vary widely. Caused-based insurance can be private, e.g., as in the United States, 
or public, e.g., as in Canada and Australia. Disability-based systems tend to be more 
generous, cover both occupational diseases/injuries and other types of diseases and injuries, 
and can be temporal or permanent. Disability-based systems are practiced in many European 
countries such as, Sweden, the Netherlands, Denmark, etc. These differences have to be 
considered when comparing results from studies on DP from different countries [39]. 
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DP policy models have been categorized in three main streams. The ‘Social-democratic’ 
policy model, the ‘Liberal’ policy model, and the ‘Corporatist’ policy model [6]. The social-
democratic model can be divided into two sub-models. The first sub-model, currently in 
Denmark, Switzerland, and the Netherlands is less generous in terms of benefits and 
employment supports, but provides better work incentives and has very strong sickness 
absence (SA) monitoring and/or sick-pay eligibility control focus compared to the other two 
models. Germany belongs to the second sub-model, together with Finland, Sweden, and 
Norway, which is the most generous model in the OECD. It covers the whole population, has 
comparatively lower entry thresholds, reasonably high benefits, and good rehabilitation 
measures. However, this sub-model involves the strongest employer obligations of all the 
models [6].  
The Liberal policy model also includes two sub-models. One, including Australia, New 
Zealand, and the United Kingdom, is very well organized and coordinated, resulting in good 
access. At the same time, it has very low compensation levels but with universal coverage. 
The other sub-model, covering Canada, the United States, Japan, and Korea, has the strictest 
eligibility criteria for a full disability compensation, including less flexible rehabilitation 
system, and the shortest sickness benefit payment duration, compared to all other models [6].  
There are three sub-models within the Corporatist policy model. The first sub-model, 
including Austria, Belgium, and Hungary, contains well developed rehabilitation and 
employment programs with lower benefit levels, thus having a stronger employment 
orientation. In the second sub-model, including France, Greece, Luxembourg, and Poland, 
there are better sickness and disability benefits compared to the other countries in the 
Corporatist cluster; they also put a focus on temporary disability benefits, and more attention 
to sickness absence. The third and biggest subgroup, including the Czech Republic, Ireland, 
Italy, Portugal, the Slovak Republic, and Spain, does not have well-developed employment 
and rehabilitation policies. This leads towards a stronger compensation orientation, though 
the level of compensation is much lower than in the other subgroups of this cluster but with a 
longer sickness compensation payment duration [6]. 
Among the European countries, the rules for SA or DP also vary in terms of qualification 
criteria, benefit levels, duration, taxation of benefit, etc. For instance, in the Netherlands, one 
has to have a loss of work capacity to a minimum extent of 15% and requires being on sick-
leave for at least two years before being granted DP, whereas, in Sweden, the extent of lost 
work capacity must be at least 25%. The benefit can reach up to 64% of the lost salary in 
Sweden or in Germany, while it can be 100% in France. In most of the countries, such 
benefits related to DP granting are fully taxable and paid up until the old-age retirement, 
whereas in Germany such benefits are exempted from tax [2]. 
1.2 The Swedish Social Insurance System 
Sickness benefit covers all individuals aged above 16 years, who are living in Sweden and 
have a minimum level of annual income from work, unemployment, or from parental   
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benefit [3]. Sickness benefit is paid in case of reduced work capacity for at least 25% due to 
disease or injury. An individual can receive 25%, 50%, 75% or 100% sickness benefit based 
on reduced working capacity. An employee usually receives compensation from the 
employer during days 2-14 of a sick-leave spell, the first day is a qualifying day and from day 
15 the compensation is paid by the Social Insurance Agency. Unemployed people and those 
on parental leave can be granted sickness benefit from the Social Insurance Agency from the 
second day of a sick-leave spell. Self-employed can have different numbers of qualifying 
days. Reimbursement by the employer is called ‘sick pay’ and by the Social Insurance 
Agency ‘sickness benefit’. Usually the first seven days of a sick-leave spell can be self-
certified, from day eight a medical certificate from a physician is also required. Around 80% 
of lost income, up to a certain level, can be paid by the Social Insurance Agency for 364 days 
within a period of 450 days. If the work capacity is still reduced, the individual can in some 
cases receive sickness benefits for longer periods, at the level of 75% of lost income - 
however, at 80% if the disease is classified as ‘severe’ [3]. 
All residents in Sweden aged 19-64 years, who due to disease or injury have a long-lasting or 
permanent reduction of their work capacity to an extent of at least 25%, can be granted 
temporary or permanent DP from the Social Insurance Agency [3]. In Sweden, DP can be 
granted for 25%, 50%, 75%, or 100% of reduction in work capacity in relation to ordinary 
working hours. Since 2003, individuals aged 19-29 years can be granted temporary DP for 
two main reasons, if their work capacity is reduced for at least one year, or due to the failure 
to complete compulsory or upper secondary school in due time [3]. DP amounts to 64% of 
lost income, up to a certain level. Those with no previous income receive a minimum specific 
amount. 
The disability pension system in Sweden has a long history [40]. In Sweden, a law on 
compensation for accidents at work was enforced in 1901, a public social insurance with 
income-related sickness benefit and subsidized health started in 1955. During the same year 
occupational injury insurance was initiated [41]. From 1972 and onwards, the eligibility 
criteria for DP also included labour market issues. In 1991, the possibility for being granted 
DP for purely labour market reasons was removed [41]. However, up through 1996, 
employees aged over 60 years could still receive DP when their unemployment benefit 
expired [41]. 
At the turn of the century, 2000, the levels of SA and DP were very high in Sweden and 
several interventions were taken to reduce the levels. The ‘halveringsmålet’ the government 
stated in 2003 (halving the ‘sick-leave rate’ = ‘sjuktalet’ in five years) was one of those 
interventions [42, 43]. In 2003, the regulations related to DP were amended in relation to age, 
that is, young individuals aged 19-29 years could be granted temporary DP if the work 
capacity was reduced for at least one year in order to complete upper secondary education. 
However, individuals aged 30-64 years, with at least 25% reduced work capacity for one year 
were still eligible for temporary or permanent DP. Before, they could be granted DP from the 
age of 16 years. In the following years there was a dramatic decrease in both SA and DP 
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incidence [3]. In 2005, a new authority, the Social Insurance Agency, was established, 
including the 21 previous regional social insurance agencies as well as a national agency 
(Riksförsäkringsverket). One of the reasons for this new authority was to decrease regional 
differences in handling of decisions regarding SA and DP [44].  
In 2008, the eligibility requirements for SA and DP were tightened. Now sickness benefit was 
limited to one year for most of the individuals and the maximum number of days of a sick-
leave spell was set at 914 days. The so called ‘rehabilitation chain’ was introduced so that 
officers at the social insurance agency were to take actions earlier in the SA trajectory. For 
instance, specific assessments were to be conducted at 90 days, 180 days, and 364 days of a 
sick-leave spell. In case of DP grant, an individual had to have a diagnosed disease or injury 
that led to a permanent loss of work capacity of at least 25% of ordinary work hours with 
regards to the entire labour market, that is, the possibility of temporary DP was removed from 
the age of 30 years [3]. 
1.3 Incidence and prevalence of disability pension 
In general, around six percent of the working-aged people across OECD countries are on DP 
[6]. In Sweden, in total 345 000 individuals were receiving temporary or permanent DP 
benefits at the end of 2015 [3]. This corresponds to a prevalence measure of six percent of the 
total working-age (19-64 years) population, thus, the same as the OECD average [3, 6]. Of 
those on DP, 58% were women. With regard to incidence measures: 8 400 and 13 000 
individuals were granted temporary and permanent DP in 2015, respectively [3]. In the age 
groups 19-29 a slightly higher proportion of men than women were on DP. In other age 
groups, starting from age 35 years, the rate of women on DP was higher, and even much 
higher in the ages 40-64 (Figure 1). 
 
 
Figure 1. Prevalence of disability pension (DP) in December 2015 in Sweden, among 
individuals aged 19-64 years, stratified by sex and age group [3].  
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The proportion of individuals applying for or being granted DP due mental diagnoses is 
increasing across the OECD countries [6, 18]. Among those with such DPs, the most 
common diagnoses for such early exit from the labour market are the CMDs [3, 6, 15, 19]. 
On an average, one in every three new DP claims is due to a mental diagnosis, rising to as 
high as 40% in some countries and nearly 50% in Denmark [6]. The highest proportions are 
found among the 20-34 age groups, with around 70% of all claims [6]. In Finland, from 1992 
to 2003, the proportions of prevalent DP due to mental diagnoses increased from 31% to 
42%, and 33% of incident DP were due to mental diagnoses in 2003 [15, 45]. In Germany, 
there was nearly a three-fold increase in the proportion of mental diagnoses among those with 
incident DP, from 1986 to 2001 (from 11% to 28%, respectively). The rate of mental and 
behavioural disorders among new recipients of DP in Iceland, from 1991 to 2004, increased 
from 15% to 29% for women and 18% to 38% for men [46, 47]. In Sweden, since 2003 
among the younger individuals aged 19-29 years and since 2007 among the older age group 
of 30-64 years, mental diagnoses form the dominant group among incident DP. In Sweden, 
mental diagnoses accounted for 86% of temporary DP in young women and 89% among 
young men granted in 2015, and corresponding figures for the older age group with 
permanent DP were 46% among women and 43% among men (Table 1) [3].  
There is a higher incidence of DP claims due to mental diagnoses among women than among 
men, and there is a higher proportion of women on DP than men [3, 6, 18, 48]. 
 
Table 1. Proportions of incident DP among individuals living in Sweden, stratified by age 
and DP diagnoses [3]. 
Sex Age 
in years 
Year of  
DP grant  
Main DP diagnosis 
Mental % Musculoskeletal % 
Women 19-29 2003 66 12 
 2015 86 02 
30-64 2003 29 44 
 2015 46 29 
Men 19-29 2003 69 05 
 2015 89 01 
30-64 2003 26 36 
 2015 43 17 
  
 7 
In Sweden, since 1998, the prevalence of DP increased persistently until 2004 followed by a 
decline from 2005 until 2012 [3, 49]. The decline in the total prevalence of DP was due to the 
decrease in the incidence of permanent DP. After 2012, the prevalence rates have been 
relatively stable. However, since 2003, the number of individuals 19 to 29 years of age on DP 
has steadily increased (Figure 2). 
 
 
Figure 2. Incidence of disability pension (DP) among individuals aged 19-29 years during 
2000 to 2015, in Sweden [3]. 
 
Among people aged above 29 years, the incidence of DP steadily declined during 2004–2011, 
and begun to rise somewhat in 2012. During 2015, around 11 700 individuals, aged 30-64 
years were granted DP (Figure 3) [3]. 
 
 
Figure 3. Incidence of disability pension (DP) among individuals aged 30-64 years from 
2000 to 2015, in Sweden [3]. 
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1.4 Socio-demographic factors and disability pension 
The associations between different socio-demographic factors and DP are well recognized 
[23, 50-58]. The existing literature suggests a higher likelihood of women to be on DP 
compared to men [23, 55, 59]. On the other hand, contradictory findings have also been 
reported. For instance, Gjesdal et al. in 2002, found no sex difference in the risk of DP when 
controlling for income and employment status, despite that a sex difference was present in the 
crude analyses [60]. Family situation also seems to play a role in the risk of being granted DP 
[55, 57, 61]. To live alone has been found to be a risk factor for subsequent DP [62]. 
Although, Dahl et al., in a study based on a Norwegian cohort, in 2000 reported that divorced 
women had a lower risk of DP, whereas divorced men had a significantly higher risk of DP 
[63]. Additionally, research findings regarding having young children at home as a risk factor 
for future DP are inconsistent and have mainly focused on women[60, 62, 64].   
Higher age has previously been reported to be associated with a higher risk of DP [60, 65-
67]. Still, particularly due to mental disorders, the incidence of DP is high in younger adults 
[3, 6, 17]. A number of studies investigated the association between low socio-economic 
status and the risk of long-term SA or DP, and reported a higher risk for subsequent DP 
among individuals with low-socio economic status [6, 51, 66, 68-73].  
Moreover, the role of type of living area as well as of regional area in granting of DP has 
been described by authors from different countries [53-55, 74-78]. In Norway, there seems to 
be a regional difference in granting of DP, both in all-cause and diagnosis-specific DP, with a 
higher frequency in the rural or semi-rural areas [54]. This association was influenced by job 
type, lower educational opportunities and poorer healthcare facilities. [54, 74, 76]. Similar 
findings regarding outpatient care due to depression were reported in Sweden by 
Mittendorfer-Rutz et al. [55]. Regional differences in the risk of DP granting in Finland has 
also been reported by Laaksonen et al., where the differences were affected by area-level 
deprivation, differences in the healthcare services, rehabilitation, and employment services 
[53, 79]. The risk of being granted DP may also vary with country of birth [55, 57, 61, 80-
82]. Among other social factors, social isolation and low social participation have also been 
found to be associated with higher risk of DP [56]. 
In addition, health-related behaviour, such as smoking, alcohol use and physical activity have 
been reported to be associated with subsequent DP [9, 83-87]. Among other health 
determinants, obesity [88-90] and sleep disturbances [91-93] are also significant risk factors 
for premature exit from the labour market in the form of DP. Different work-related factors, 
e.g., heavy physical job type, poor working conditions, high job strain, shift work, effort-
reward imbalance and low job control  have been associated with future DP [94-101]. 
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1.5 Medical factors and disability pension 
Different medical factors, such as healthcare use, psychotherapies, or prescriptions of 
psychiatric medication before being granted DP may reflect the severity of an underlying 
mental disorder, due to which DP is granted, and might act as predictors for DP granting. On 
the other hand, mental health of individuals after being granted DP can be evaluated by the 
frequency of healthcare use, by assessing prescriptions of psychiatric medication, etc. during 
the post-DP period. In this PhD project, medical factors included in- and specialized 
outpatient care due to mental and somatic diagnoses (study I, II, III, and IV), inpatient care 
due to suicide attempt (study I and II) and prescribed dispensed antidepressants (study I and 
IV) or anxiolytics (study I). 
Below is a brief description about healthcare use and prescription of ADs in individuals 
granted DP. 
1.5.1 Disability pension and specialized healthcare use 
In general, frequency and patterns of healthcare use might be related to the type of disease 
and may reflect its clinical severity. The more severe cases are usually treated by specialists 
either at specialized outpatient care or at inpatient care facilities. Therefore, it can be assumed 
that individuals, with a disease leading to work incapacity, are likely to have a high degree of 
severity of the disorder and are supposed to go through different and extensive healthcare and 
rehabilitation measures prior to applying for DP. Moreover, CMDs have a good prognosis 
with treatment and rehabilitation methods, which are relatively well accessible, and they are 
likely to worsen with inactivity [102-104]. Therefore, granting of DP, which in fact is 
enabling or even more promoting inactivity by exclusion from the labour market, would be 
less anticipated. Surprisingly, the majority of the DP applications throughout Europe today 
are due to mental diagnoses, and CMDs are the most common among them [2, 3, 6, 15]. 
Adequate healthcare measures before considering a DP claim are, therefore, crucial in order 
to prevent transition to DP. Existing scientific knowledge regarding this issue, though very 
scarce, indicate an inadequate treatment before the DP grant in terms of healthcare use, 
pharmacotherapy, and psychotherapy [105-107]. Similar findings were reported by Eisenberg 
et al. in 2007 when investigating help-seeking and access to mental healthcare in a university 
student population [108]. The scientific literature on the pattern of healthcare use among the 
DP individuals suggests an immediate decrease following DP, but still much higher 
compared to those retired not due to health reasons [109], or even lower compared to those 
with similar clinical features and not on DP or denied DP [110]. Beckman et al., reported in 
2006, that socio-demographic factors like country of birth, family situation, education, etc. 
may also affect the granting of DP by affecting healthcare use patterns [61]. Suboptimal 
treatment of the disorder leading to DP may also depend on the living area due to access to 
healthcare by altering the help seeking behaviour or due to lack of skilled personnel causing 
longer waiting time, or due to lack of facilities, e.g., beds, at the healthcare center [53, 76, 
111]. 
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1.5.2 Disability pension and antidepressant use 
Adequate pharmacological treatment during the pre-DP period may play a crucial role in 
terms of preventing DP due to mental disorders. Specifically, when impaired functioning is 
due to depression, adequate pharmacotherapy may reduce symptoms and improve 
productivity [112-114]. In Swiss studies, conducted in 2002 and 2004, on individuals 
claiming DP due to mental diagnoses, it was reported that only 20% and 37%, respectively, 
received adequate pharmacotherapy before applying for DP [115]. Similar findings were also 
reported from Finland and Norway [106, 107, 116]. Trajectory studies of AD prescriptions or 
purchases in individuals on DP due to mental disorders may contribute to depict the treatment 
situation in terms of dosages and trend. Laaksonen et al. [30], in 2012 reported an increase in 
purchases of psychiatric medication, measured by calculating defined daily doses (DDDs), 
particularly in ADs during the pre-DP period, which was then decreased in the post-DP 
period. The DDD, as defined by ‘the WHO collaborating center for Drug Statistics 
Methodology’, is the tentative average maintenance daily dose for a medication, used as it’s 
main indication in adults [117]. However, looking at the amount of purchases one year before 
the DP grant, which was around 40 DDDs in a three months’ interval per individual, one 
could suspect a suboptimal treatment [30]. Similar findings regarding AD trajectories were 
reported by other Finnish researchers [31, 32]. 
In addition to the specialized healthcare factors, previous prescriptions of antidepressants and 
anxiolytics were also taken into account for study I. In study IV, trajectories of prescribed 
ADs were identified and studied during the pre- and post-DP periods. 
1.6 Potential outcomes of being on disability pension 
Most of the scientific research has so far focused on risk factors rather than potential 
outcomes of being on DP (Tables 2 and 3). Among the studies on different outcomes 
following granted DP, the majority have emphasized the higher risk of premature death 
among people on DP compared to in the general population [20-22, 24, 118-127]. Studies 
also suggest a higher suicide risk in people on DP compared to the general population [21, 
24, 25, 120, 127, 128]. Previously, DP has also been shown to be a risk factor for suicide in a 
population-based longitudinal study in the Danish population [25]. Although, Hult et al. 
claimed that there is no association between DP per se and higher mortality, stating that it is 
rather the DP diagnosis that explains the higher mortality among people on DP [129]. 
There is an association between main DP diagnoses, particularly mental diagnoses and higher 
mortality, including due to suicide [21, 24, 120, 126, 130]. It can be assumed, that similar to 
the general population, this risk might be considerably higher when comorbid with other 
mental or somatic disorders [131-137]. Sick-leave duration of more than 90 days due to a 
mental diagnosis is reported to be associated with a higher risk for all-cause mortality and 
suicide [138]. Additionally, higher suicide risk immediately following granted DP [119, 121] 
may indicate a possible association between duration of DP and subsequent higher risk of 
premature death including suicide. DP grade, which can be seen as a reflection of the severity 
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of the DP diagnosis, has also been shown to be associated with subsequent suicidal behaviour 
[121, 139].  
Long-term or permanent exclusion from the labour market due to DP may adversely 
influence health due to lack of positive effects from paid work, including social contacts with 
colleagues, prospects of career and income progression, a sense of purpose, or even daily 
routines and structures [140]. Additionally, DP or long-term SA itself may imply alterations 
of health behaviour (e.g., regarding alcohol and tobacco use, exercise, diet) or social isolation 
[141, 142]. 
In general, studies on trajectories of purchased ADs, show an increase in such purchase until 
the DP grant, especially during the DP granting year, and particularly in individuals granted 
DP due to mental diagnoses [30-32]. The trajectories would immediately decline following 
granted DP with a further stabilization in purchase of ADs [30-32]. Disability pension has 
also been shown to be a predictor of benzodiazepine use 20 years after granted DP in a study 
from Norway [143].   
Overland et al., while studying health status of DP recipients before, during, and after DP 
grant, reported a ‘U-shaped’ trend of symptom level, including mental, somatic, pain 
distribution, sleep problems, etc. [33]. From ‘the 2000 Psychiatric Morbidity Survey’, carried 
out in the UK, Buxton et al., in 2005, reported a higher prevalence of CMD among men who 
were already on DP compared to their working peers, while such differences were not 
obvious in women [144]. In another UK study, conducted by Pattani et al. in 2004, surveying 
national health service employees, concluded that despite improvements in the quality of life 
(QOL) among DP recipients following a year after DP grant compared to the QOL at 
baseline, it was still significantly poorer compared to their working colleagues, and to those 
who had returned to work [145].  
A survey by Ejlertsson et al., of individuals on DP due to Musculoskeletal diagnoses, was 
carried out in 1992 and 1994 in Kristianstad municipality, Sweden [146]. The aim of the 
study was to find predictors of positive health1 among such DP recipients. The authors 
reported that the high age (55 or more years) and not being an immigrant, absence of 
fibromyalgia and other general pain disorders, no regular use of analgesics to be predictors of 
positive health, and recommended extend rehabilitation efforts, focusing on how to cope with 
chronic pain, especially for the individuals younger than 55 years. They also advised to 
intensify efforts to support immigrants to adjust to situations related to ill-health and 
                                                 
1 Positive health was defined based on the two questions, ‘How would you describe your overall health status at 
present?’ (answers: good, neither/nor, poor) and ‘How would you describe your health status today in 
comparison with two years ago?’ (answers: better, unchanged, worse). If an individual answered good health in 
1994 and for whom the health status had not deteriorated in the last two years then it would be considered as 
positive health. Similarly, negative health was defined a poor health status in 1994, and health status had not 
improved in last two years. 
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retirement and to strengthen activities of daily living in DP recipients to support an 
independent active life. 
In another study among men on DP from Eskilstuna, Sweden, the authors reported higher 
healthcare use among men on DP aged between 30-54 years compared to men of similar age 
group (reference group) from the general population [109]. Over time, healthcare use 
declined among DPs and was constant in the reference group, however, it remained twice as 
high compared to the reference group. Below are tables 2 and 3 showing possible outcomes 
of being on DP.
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Table 2. Studies on disability pension (DP) and mortality.  
Author, year 
published, 
country 
Study design; 
Type of data 
Study period  Exposure   Outcome 
measures  
Total study 
population  
Covariates  Results  
Qin et al. 2000 
[147], 
Denmark 
Retrospective 
case control, 
register  
1980-1994 DP  Suicide  811 suicide cases, 
79 871 controls  
Family situation, socio-
economic status (SES),  
type of living area, labor 
market participation incl. 
DP, psychiatric admission, 
alcohol/drug use  
DP was associated with higher risk of 
suicide only in crude analysis 
Quaade et al. 
2002 [119], 
Denmark 
Prospective 
cohort study, 
registers  
1986-1996 DP and early 
retirement (latter 
is earned through 
long-term 
membership in 
unemployment 
benefit scheme) 
All-cause 
mortality 
Total Danish 
population born 
between 1926-1936 
Age, sex, primary 
occupation (including old 
age pension. disability 
benefit, and early 
retirement benefit ) 
DP was associated with higher risk for 
mortality, the association was even 
stronger than with early retirement; 
risk was highest immediately after 
granted DP 
Qin et al. 2003 
[25], Denmark  
Retrospective 
case control, 
register 
1981-1997 DP Suicide  21 169 suicide 
cases, 423 128 
controls   
Family situation, SES, type 
of living area, labor market 
participation incl. DP, 
ethnicity, psychiatric 
admission 
DP was associated with higher risk of 
suicide in both men and women, also 
in multivariate models 
Ahs et al. 2006 
[127], Sweden 
Prospective, 
questionnaire 
survey 
1984–1989 and 
1992–1997 
Employment 
status  
All-cause and 
cause-specific 
mortality 
Unemployed 2067, 
retired/ temporal DP 
2674, economically 
inactive for other 
reasons 1373, 
employed 38 293 
Age, sex, education, family 
situation, country of birth, 
type of living area, 
longstanding illness, self-
rated health, previous 
unemployment 
Higher risk of mortality including 
suicide especially among those on 
temporary DP and only suicide among 
the unemployed 
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Author, year 
published, 
country 
Study design; 
Type of data 
Study period  Exposure   Outcome 
measures  
Total study 
population  
Covariates  Results  
Wallman et al. 
2006 [20], 
Sweden  
Prospective 
cohort, registers  
1971-2001 DP All-cause and 
cause-specific 
mortality  
6887 persons 
younger than 65 
years at baseline 
(1683 (24.4%) were 
on or receiving DP 
at baseline) 
Age, sex, diagnosis, family 
situation, education, 
smoking, drug use, hospital 
admission   
Higher risk for mortality among DP; 
risk declines with age 
Bambra C et al. 
2006 [148], 
UK 
Ecological study 2002 Sickness absence 
(SA) > 1 year 
(equivalent to DP 
in Sweden) 
All-cause and 
cause-specific 
mortality and 
self-rated health  
376 local 
government areas  
 Medically certified SA (>1 year) is 
associated with a higher risk of all-
cause mortality  
Karlsson N, 
2007 [122], 
Sweden  
Prospective 
cohort studies, 
register, records  
1985-1996 DP diagnoses All-cause and 
cause specific 
mortality 
143 933 persons, 16-
64 years old 
Age, sex  All-cause DP was associated with 
higher mortality due to same and 
different diagnoses; no association 
with DP due to labour market reasons; 
high risk for suicide in both sexes due 
to mental diagnoses, and in men due to 
cardiovascular diagnoses 
Karlsson et al. 
2007 [121], 
Sweden  
Prospective 
cohort study, 
records, 
registers 
1985-1996 DP (full- and 
part-time, and due 
to labour market 
reasons)  
All-cause 
mortality  
245 704 persons, 16-
64 years old  
Age, sex  Higher risk of mortality with DP in 
both sexes and all age groups, 
particularly in the youngest; lower risk 
with part-time DP, and for labour 
market reasons  
Gjesdal et al. 
2008 [149], 
Norway  
Prospective 
cohort study  
1990-1996 DP all-cause and 
diagnosis specific 
All-cause 
mortality  
148 942 persons  Age, education, income  DP was associated with higher 
mortality with exception of men with 
musculoskeletal diagnoses (MSD), the 
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Author, year 
published, 
country 
Study design; 
Type of data 
Study period  Exposure   Outcome 
measures  
Total study 
population  
Covariates  Results  
effect was stronger in men when 
adjusted for income and education  
Gjesdal et al. 
2009 [124], 
Norway 
Prospective 
cohort study. 
register 
1994-2003 DP all-cause and 
diagnosis specific 
All-cause 
mortality 
2492 persons Age, sex, income, DP 
diagnosis 
DP was associated with higher 
mortality; men with mental diagnoses 
had higher risk for DP and mortality 
than men with MSD; higher risk of 
mortality among men of higher age 
and low income  
Gjesdal et al. 
2009 [22], 
Sweden, 
Norway 
Prospective 
cohort. 
Registers 
1990-1996 DP all-cause and  
diagnosis specific  
All-cause 
mortality 
71 293 women, 76 
928 men from 
Norway, and 68 181 
women and 7950 
men from Sweden 
Age, sex, DP diagnosis Higher mortality, especially among 
male workers 
Hult et al., 
2010 [129], 
Sweden 
Prospective 
cohort, registers 
1971-1993 DP all-cause All-cause 
mortality 
24 369 male 
construction 
workers 
Age at DP grant, DP grade DP per se was not associated with 
higher mortality, rather illness 
explained it 
Shaw et al., 
2011 [118] 
Retrospective 
cohort, registers 
Census 1981, 
1986, 1991, 
1996, 2001 
each with 3 
years follow-up 
Sickness benefit 
(SB) and 
Incapacity benefit 
(IB) 
All-cause 
mortality 
14 373, 20 307,        
26 016, 39 090,        
45 840, respectively 
Age, sex SB and IB was associated with higher 
mortality 
Leinonen et al. 
2013 [120], 
Finland  
Prospective 
cohort, registers 
1997-2007 DP due to mental 
diagnosis 
All-cause and 
cause specific 
mortality 
392 985 with no 
prior DP due to 
Age, social class, living 
arrangement 
Higher mortality among DPs due to 
depression and other mental diagnoses 
 16 
Author, year 
published, 
country 
Study design; 
Type of data 
Study period  Exposure   Outcome 
measures  
Total study 
population  
Covariates  Results  
mental diagnoses at 
baseline 
compared to non-DP; especially for 
unnatural and alcohol-related death 
Björkenstam et 
al. 2014 [21], 
Sweden 
Prospective 
cohort, registers 
1996-2009 All-cause and 
diagnosis-specific 
DP 
all-cause and 
cause-specific 
mortality 
Cohort 1995: 5 006 
523 (DP 37 945)  
Cohort 2000: 5 066 
144 (DP 45 302) 
Cohort 2005: 5 072 
599 (DP 58 146)  
Age, sex, family situation, 
education, living area, 
country of birth, previous 
inpatient care 
Higher mortality risk among people 
granted DP; higher suicide risk in DP 
due to MSD, neurological, mental 
diagnoses 
Narusyte et al. 
2014 [125], 
Sweden 
Prospective twin 
cohort, registers 
1996-2008 1 .SA 
2. SA or DP 
1. DP 
2. Mortality 
59 598 (twin 
individuals) 
Age, sex, zygosity 1. Incident SA was associated with 
higher risk of subsequent DP  
2. SA or DP were associated with 
higher mortality risk 
Very little influence from familial 
factors  
Polvinen et al. 
2015 [126], 
Finland 
Prospective 
cohort, registers 
1987-2007 All-cause and 
diagnosis-specific 
DP 
Cause-specific 
mortality 
58 937 men and 
52 289 women 
Age, sex, DP diagnosis, 
SES 
Higher mortality among DPs 
compared to non-DPs; manual workers 
had a higher risk of mortality than 
upper non-manual employees 
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Table 3. Studies on disability pension (DP) and different outcomes.  
Author, year 
published, 
country 
Study design; 
Type of data 
Study period  Exposure   Outcome 
measures  
Total study 
population  
Covariates  Results  
Ejlertsson et 
al. 2002 [146], 
Sweden  
Survey, 
prospective, 
questionnaires  
1992-1994 DP due to MSD  Positive self-
reported health  
352 DPs Household composition, 
healthcare and medication 
use, SES, psychosocial 
determinants, perception of 
life situation  
Positive health was associated with 
older age, not being an immigrant, 
not having fibromyalgia, no regular 
use of analgesics, positive subjective 
health before the study period 
Wallman et al. 
2004 [109], 
Sweden  
2 cohort studies, 
questionnaires, 
registers 
1986-1999 DP Diagnosis-specific 
healthcare use 
from 5 years 
before to 13 years 
after retirement 
215 men (30-54 
years) on DP, 620 
referents from 
general population 
(same age) in 
Eskilstuna of 
Sweden 
Education, smoking habits, 
employment and family 
situation  
Men on DP had a higher risk for 
healthcare use at baseline and follow-
up 
Pattani et al. 
2004 [145], 
UK  
Prospective 
cohort study, 
survey 
questionnaires 
1998-1999 DP Return to work 
(RTW) under 
same or different 
employer, quality 
of life (QOL) 
1317 employees 
with DP 
SES, age, sex, type of 
employment, marital status, 
ethnicity 
RTW improved QOL, but it was still 
lower in DPs compared to the general 
population, lower age and better 
QOL at baseline predicted RTW  
Hartz et al. 
2009 [143], 
Norway 
Prospective 
cohort, health 
survey 1985-1989 
and prescribed 
drug register 
2004-2006 
2004-2006 DP Later prescription 
of 
Benzodiazepines 
6645-men 
6455-women 
Age, gender, alcohol use and 
smoking, marital status, 
physical activity, use of 
analgesics, and somatic 
(cardiovascular morbidity) 
and mental health problems  
About 20% of all men and 30% of all 
women reporting being on DP at the 
age of 40 years had started 
benzodiazepines 20 years later, a 
period covering most of their 
potential workforce period 
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Author, year 
published, 
country 
Study design; 
Type of data 
Study period  Exposure   Outcome 
measures  
Total study 
population  
Covariates  Results  
Øverland et al. 
2008 [33], 
Norway 
Prospective 
cohort, HUSK 
survey and DP 
register 
7 years before 
to the 7 years 
after granted 
DP (DP register 
January 1992 to 
December 
2004) 
DP Health status 8598 men  
9983 women 
Depression, anxiety, somatic 
symptoms, pain distribution, 
sleep problems, physical 
diagnoses, blood pressure 
medication 
For most measures, the level of 
health problems was equal 3–7 years 
before compared to 3–7 years after 
granted DP, the exceptions being an 
increase in prescribed medication and 
more sleep problems after granted 
DP 
Oksanen et al. 
2011 [32], 
Finland 
Prospective 
cohort, registers 
9 years Retirement 
(including DP) 
Use of ADs and 
diabetic 
medications 
11 019 Sex, SES, geographic area 
(Southern, Middle, Northern 
Finland, based on the 
location of the workplace), 
and type of employer (town 
or hospital), long-term SA, 
chronic disease 
Statutory retirement: decreased AD 
purchase during from 1 year before 
to 1 year after retirement (more 
decrease for high SES, history of 
long-term SA), increased for men in 
post-retirement.                                
DP due to mental diagnoses: AD 
purchase increased in pre-retirement, 
peak in retirement year, decrease in 
post-retirement, more decrease in 
high SES.                                          
DP due to somatic diagnoses: AD 
purchase increased in pre-retirement 
but little decrease in transition or 
postretirement  
Laaksonen et 
al. 2012 [30], 
Finland 
Prospective 
cohort, registers 
10 years of 
observation for 
incident old age 
pension (OAP) 
and DP granted 
 Trajectories of 
ADs, hypnotics 
and sedatives 
DP (N=2549)  
OAP (N=4456), 
 
Sex, retirement year, age at 
retirement and social class  
Steep increase in purchases of 
psychiatric medication before DP, 
following decreased purchase of ADs 
after granted DP due to mental 
diagnoses 
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Author, year 
published, 
country 
Study design; 
Type of data 
Study period  Exposure   Outcome 
measures  
Total study 
population  
Covariates  Results  
during 2000-
2008 
Leinonen et 
al. 2013 [31], 
Finland 
Prospective 
cohort, registers 
15 years of 
observation for 
incident OAP 
and DP granted 
during 1997-
2007 
 Trajectories of 
ADs 
DP (N=42 937) 
OAP (N=19 887) 
DP (N=2549)    
OAP (N=4456) 
 
Sex, calendar year, age at 
retirement, social class, 
family situation  
Increased purchase of ADs before 
DP, especially steep among those 
retiring as DP due to depression and 
other mental disorders, with a decline 
in similar purchases following DP 
grant  
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1.7 Conceptual framework 
In all four studies of this PhD thesis, the focus was on the future life situation after being 
granted DP due to CMD regarding psychiatric morbidity and suicidal behaviour. Suicidal 
behaviour here refers to suicide attempt and suicide. Risk factors for suicidal behaviour 
following being granted DP were assessed in study I and II, and healthcare use frequencies 
and trajectories (study III) along with amounts of prescribed dispensed ADs (study IV) were 
considered before and after granting of DP. A conceptual framework for the four studies is 
presented in Table 4.  
Table 4. Conceptual framework of the performed studies in this thesis according to a 
structure for categorizations of studies on sickness absence (SA) and disability 
pension (DP) [150]. Those relevant for this thesis are marked in bold. 
What is studied  -Design 
-Studied 
-Data 
-Analyses 
Scientific 
discipline  
Perspective 
taken in 
research 
questions  
Structural 
level of factors 
included in the 
analyses  
Diagnoses  
1. Factors that 
hinder or promote 
sickness 
absence/disability 
pension 
2. Consequences of 
(being on) sickness 
absence/ disability 
pension 
3. Factors that 
hinder or promote 
return to work 
4. Sickness 
certification 
practice 
5. Methods, theories  
Study design 
-Cross sectional 
-Longitudinal 
-RCT, CT, etc. 
 
Studied 
General 
population 
Insured 
In paid work 
(general or 
special) 
Diagnosed 
On SA/DP 
Other 
 
Type of data 
Interview 
Questionnaire 
Register 
Medical files 
Insurance files 
Notes 
Documents 
Video 
Other 
 
Type of 
analyses 
-Qualitative 
-Quantitative 
Economy 
Law 
Management 
Medicine 
Psychology 
Sociology  
Public health 
Epidemiolog
y 
Philosophy 
Other  
 
That of the: 
 
-Society 
-Insurance 
-Healthcare 
-Employer 
-Family 
-Patient 
-National 
-Local 
-Worksite 
-Healthcare 
-Family 
-Individual 
All together 
 
Mental 
Musculoskeletal 
Cancer 
Circulatory 
Infections 
 
Other  
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1.8 Common mental disorders 
In 2014, the World Health Organisation (WHO) defined mental health as, “a state of well-
being in which every individual realizes his or her own potential, can cope with the normal 
stresses of life, can work productively and fruitfully, and is able to make a contribution to her 
or his community” [151]. Mental disorders have been defined as “health conditions that are 
characterized by alterations in thinking, mood, or behavior (or some combination thereof) 
associated with distress and/or impaired functioning” [152]. The two concepts of ‘mental 
health’ and ‘mental disorders’ are not distinct, rather it is the presence of one or the other as a 
continuum which determines the human behaviour. Common mental disorders (CMD) are 
mental conditions that cause marked emotional distress and interfere with daily function, 
[153]. The most common mental disorders, therefore referred to as ‘Common mental 
disorders’, include depressive, anxiety, and stress-related mental disorders [153-160]. These 
disorders are labeled as CMD in this thesis. In general, CMDs are more prevalent among 
women, whereas men tend to have a higher prevalence of substance abuse disorders [155, 
157, 160]. The onset of mental disorders often occurs already in childhood or adolescence, 
and anxiety disorders might have an earlier age of onset than depressive disorders [160, 161]. 
Risk factors for CMDs may include socio-economic status, comorbid mental or somatic 
disorders, ethnicity, family history of CMD, and family situation [160]. 
Common mental disorders share a number of common etiological factors, are often 
comorbid, and have similar treatment and rehabilitation measures [102, 153, 160, 162, 163]. 
The symptoms of such disorders can include not only loss of interest, fatigue, sleep 
complaints, poor concentration, and subsequent forgetfulness, but also indecisiveness and 
reduced attention, agitation and irritability, social withdrawal and somatic pain, which in turn 
may play a detrimental role in terms of work incapacity [160, 164]. Common mental 
disorders can strongly impact individuals’ quality of life by affecting social and occupational 
functioning [165-169], and thereby causing temporary or permanent exclusion from the 
labour market [11, 170-176], and may even lead to suicidal behaviour [131-135, 177-184]. 
Moreover, such disorders are likely to worsen with inactivity, e.g., exclusion from work, 
while adequate treatment and rehabilitation efforts are found to enhance a positive prognosis 
[102-104]. Nevertheless, CMDs have become one of the leading causes of DP claims and 
labour market marginalization in many European countries [2, 6, 15, 17, 18, 185]. Depressive 
disorders, for example, are a major contributor to the global burden of disease [186] and 
predicted to be the leading cause of loss of disability adjusted life years (DALYs) in high-
income countries by 2030 [187]. 
1.8.1 Incidence and prevalence of common mental disorders 
In general, CMD may affect up to 15-20% of the population at any given time [154, 155, 157, 
158, 160]. In Western countries, the lifetime prevalence of any mental disorder is up to 25% 
in the general population, whereas the 12-month prevalence is around 10% [158]. Globally, 
more than 350 million people suffer from depression [186]. The lifetime prevalence of any 
depressive disorder is around 14%, which is similar to the lifetime prevalence of any anxiety 
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disorder [154, 158] . In 2013, Johansson et al. conducted a study to investigate the point 
prevalence of depression, generalized anxiety disorder, anxiety disorders in general, and 
comorbidity in a Swedish sample [162]. The study concluded that, about 17.2% of the 
Swedish general population experience clinically significant depression (10.8%) or anxiety 
(14.7%) that are likely to affect their daily lives [162]. It should be noted that symptoms of 
depression were measured by the 9-item Patient Health Questionnaire Depression Scale 
(PHQ-9) and anxiety was measured by the 7-item Generalized Anxiety Disorder Scale 
(GAD-7). The PHQ-9 has a total score between 0 and 27, each item is valued between 0 to 3 
(0: Not at all; 1: Several days; 2: More than half of the days; 3: Nearly every day). Total 
scores of 0–4 indicate no depression, 5–9 mild depression, 10–14 moderate depression, 15–
19 moderately severe depression and 20–27 severe depression [188]. GAD-7 has a maximum 
total score of 21; each of the 7 items can be scored between 0 and 3. While the cut-off of 10 is 
optimal for detecting GAD, a cut-off of 8 has been found to maximize sensitivity (77%) and 
specificity (82%) when detecting any anxiety disorder [189]. 
1.9 Suicide and suicide attempt 
Suicide, as defined by WHO, is the act of deliberately taking one’s own life [190]. It has 
become the second leading cause of death globally among 15-29 year olds and nearly one 
million people worldwide are estimated to end their lives by means of suicide every year 
[191]. The global annual age-standardized suicide rate was reported to be 11.4 per 100 000 
inhabitants (15.0 for men and 8.0 for women) in 2012 [192].  
In Western countries, men are more likely to die from suicide than women, whereas such 
differences might not be present in Asian countries [133, 193, 194]. Suicide rates increase 
with increasing age and are highest in individuals aged 70 years and older regardless of sex in 
almost all regions of the world [192]. Suicide rates may vary widely between regions and 
countries in Europe, such rates are generally higher in northern European countries than in 
southern European countries [133]. Former Soviet states, particularly Baltic countries, 
Russian Federation, Belarus and Ukraine, still have the highest suicide rates in Europe [192, 
195]. In 2015, the overall suicide rate in Sweden was 11.6 per 100 000 inhabitants, 16.8 being 
attributed to men and 6.8 to women. The overall Swedish suicide figure was similar to the 
European-28 average suicide rate which was 11.7 in 2013 [194]. In Sweden, suicide rates 
were high particularly among those 25 years and older in the early 1980s (Figure 4) [196]. 
Since 1984, there has been a steady decrease in suicide rates in individuals aged 25 years and 
older, though the youngest group, including individuals 15-24 years, showed stable suicide 
trends without any notable decline (Figure 4) [196].  
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Figure 4. Suicide rates per 100 000 inhabitants in different age groups in Sweden, 1980-2015 
[196]. 
 
Suicide attempt on the other hand, is as much as twenty times more frequent than suicide in 
the general population [192]. It is also amongst the most important risk factor for subsequent 
suicide [132, 133, 193, 197-200]. Suicide attempt can be defined as “a non-fatal, self-
directed, potentially injurious behaviour with an intent to die as a result of the behavior” 
[201]. There exists a wide range of terms regarding ‘self-harm’, e.g. ‘deliberate self-harm’, 
‘intentional self-harm’, ‘parasuicide’, ‘self-poisoning or self-injury’, ‘self-mutilation’, ‘self-
directed violence’, etc. [200-202], each of which may differ with regard to intent or 
motivation to die and outcome of such behaviour. It might be difficult to determine the intent 
behind such behaviour. 
In the ‘WHO/EURO Multicenter Study’, suicide attempt was defined as “an act with non- 
fatal outcome, in which an individual deliberately initiates a non-habitual behaviour that, 
without intervention from others, will cause self-harm, or deliberately ingests a substance in 
excess of the prescribed or generally recognized therapeutic dosage, and which is aimed at 
realizing changes which the subject desired via the actual or expected physical consequences” 
[202]. In this thesis, the term ‘suicide attempt’, similar to the definition of the WHO/EURO 
multicenter study has been used.  
In contrast to suicide, suicide attempt is usually more frequent among women and younger 
individuals compared to men and older individuals, respectively [135, 192, 202-204]. Age-
standardized suicide attempt rates are higher in the northern part of Europe than in the 
southern parts [202]. In Sweden, suicide attempt rates for individuals 25 years and older are 
more or less at the same level from 1987 to 2014 (Figure 5). However, there was a sharp 
increase in suicide attempt rates among individuals 15-24 years of age during 1997-2007, 
with a subsequent decline. Still, rates stayed at a higher level than in 1997 (Figure 5) [205]. In 
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2014, the age-standardized total suicide attempt rate (i.e. inpatient care due to suicide 
attempt) in Sweden was 102.7 (84.5 for men; 120.7 for women) [205]. 
 
 
Figure 5. Suicide attempt rates per 100 000 inhabitants in different age groups in Sweden 1987-
2014 [205]. 
 
The outcome of a suicidal behaviour, whether fatal or non-fatal, may largely depend on the 
method of such behaviour [133, 206]. Method, in turn, may depend on the availability, sex, 
and geographical location [207, 208]. Usually, in the high-income countries, men tend to use 
more violent methods, such as hanging or shooting, whereas women are more prone to use 
poisoning or jumping from high place [133, 192]. Globally, hanging accounts for about 50% 
of suicides in the high-income countries, and firearms for about 18%, however, in the WHO 
region of the Americas, firearms are used in almost 50% of the suicides. In other high-income 
countries firearms account for only around five percent of all suicides [192, 209].  
Suicidal behaviour (i.e., suicide attempt and suicide) is a sensitive issue, or even illegal act in 
many countries. It is often under-reported and can be misclassified to some extent as an 
accident or another cause of death in the records even in countries with good statistics [133, 
192, 210, 211]. The majority of the suicide attempts do not end up at a healthcare settings and 
only about one in every fourth suicide attempter receives treatment in specialized healthcare 
[200, 212].  
In Sweden, in case of a suspected unnatural death, which is decided by the police, the 
Forensic Department carries out examination of the deceased, often with an autopsy, to 
determine the cause of death [213]. Since the 1990s, about 97% of all suicide cases have been 
autopsied by the Forensic Autopsy Department. The death certificate, which includes 
information regarding the cause of death, is then submitted to the National Board of Health 
and Welfare. Then, all diagnoses and injuries reported on the certificate are converted into 
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codes of the International Classification of Diseases (ICD-codes). The ICD is the standard 
diagnostic tool developed by WHO, used mainly in epidemiology and research, health 
management and clinical purposes. Applications include monitoring the incidence and 
prevalence of a disease, observing reimbursements and resource allocation trends, and 
keeping track of safety and quality guidelines. They also include the counting of deaths as 
well as diseases, injuries, symptoms, reasons for encounter, factors that influence health 
status, and external causes of disease [214]. Since 1969, when the 8th revision of ICD was 
introduced, it became possible to classify death as an undetermined intent [213]. Suicidal 
behaviour can be deliberate with a clear intent or determination to die and regarded as 
intentional self-harm. However, in many cases it is difficult to detect or understand the intent 
of such behaviour. As a result, suicidal behaviour is often underreported or reported as 
undetermined cause [211, 215]. It is an accepted practice to combine determined and 
undetermined intent in order to limit under-reporting of suicide attempt or suicide and to 
account for temporal and geographical differences in ascertainment methods [216-218]. This 
approach has also been used in this thesis. 
1.9.1 Risk factors for suicide and suicide attempt 
Previous suicide attempt is reported to be the strongest risk factor for subsequent suicide 
attempt and suicide [131-133, 219, 220]. Around 16% of the suicide attempters repeat 
attempt and two percent of the attempters die by suicide in the following year and over five 
percent die by suicide within nine years of an attempted suicide [220].  
Female sex and younger age are risk factors for suicide attempt [135, 200, 202, 209, 221], 
whereas, male sex and older age are risk factors for suicide [133, 209, 222]. Suicidal 
behaviour has also been reported to be more frequent among people with lower level of 
education, with low socio-economic status, unemployed, unmarried or divorced [135, 178, 
192, 200, 202]. Adverse childhood experience or adverse life events during adulthood, 
critical family situation, social isolation are reported to be associated with suicidal behaviour 
[217, 223-225]. Such behaviour may also have genetic predisposition [226, 227].  
Mental disorders are main risk factors for suicide and suicide attempts [133, 193, 200, 209]. 
The majority of the suicide attempters suffer from anxiety disorder [134, 183, 200, 228], and 
depressive disorders have been found to be the strongest risk factors for any suicidal 
behaviour [103, 131, 132, 136, 229-231]. Depression with comorbid anxiety increases the 
risk for suicide [131, 133, 163, 232, 233]. Additionally, substance abuse disorders, 
specifically alcohol abuse has been shown to be a risk factor for suicidal behaviour [132, 135, 
234-236]. Personality disorders, either independently or comorbid with other mental 
disorders, have also been reported to increases the risk of suicidal behaviour [177, 237, 238].  
A wide range of somatic disorders, comorbid with depressive disorder, have been shown to 
be associated with suicidal behaviour, especially, cancer [239], multiple sclerosis [240], 
stroke [241], HIV/AIDS [242-244], chronic pain-related disorders [245], epilepsy [246, 247], 
injury [248] are associated with suicidal behaviour [132, 133, 178]. 
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In this thesis, associations of different socio-demographics and medical factors with suicidal 
behaviour among individuals on DP due to CMD were tested. Socio-demographic factors 
included age, sex, education, country of birth, type of living area, and family situation, 
whereas in- and specialized outpatient care due to mental/somatic diagnoses, inpatient care 
due to suicide attempt and prescribed antidepressants or anxiolytics were tested as medical 
risk factors. 
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2 Aim 
2.1 Overall aims 
To gain knowledge about the association of DP due to CMD with subsequent psychiatric 
morbidity and suicidal behaviour in the general population of Sweden. 
2.2 Specific aims 
2.2.1 Study I 
This study aimed to explore whether different socio-demographic factors, healthcare use, and 
medication were associated with suicidal behaviour (suicide and suicide attempt) in 
individuals on DP due to CMD. 
2.2.2 Study II 
This study aimed to examine 1) how different measures of DP (main diagnosis, secondary 
diagnosis, duration, and grade) were associated with subsequent suicidal behaviour (suicide 
attempt and suicide) in individuals on DP due to CMD and 2) possible differences in these 
associations with regard to sex and age. 
2.2.3 Study III 
The aims were to study 1) in- and specialized outpatient healthcare use among individuals 
granted incident DP due to CMD over a 7-year period (three years prior, the year during, and 
three years after being granted DP) and 2) whether these trajectories differed before and after 
the introduction of stricter DP granting criteria in Sweden in 2008. 
2.2.4 Study IV 
The aims of the study were 1) to identify and describe different types of trajectories of 
prescribed dispensed ADs among individuals receiving DP due to CMD during 2009-2010 
over a 6-year period (three years prior, and three years after being granted DP), and 2) to 
characterize the trajectory groups with regard to socio-demographics and previous healthcare 
use.
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3 Methods 
The methods of the four studies are summarized in Table 5. 
3.1 Design and study population 
All four included studies were population-based, prospective in nature, and based on Swedish 
nationwide register data. The population included in this PhD project, was exclusively on DP 
(incident or prevalent) due to CMD, which comprised the following ICD-10 diagnostic 
codes: F32 (depressive episode), F33 (recurrent depressive disorder), F40 (phobic anxiety 
disorder), F41 (other anxiety disorder), F42 (obsessive-compulsive disorder), and F43 
(reaction to severe stress, and adjustment disorder) [164]. 
Study I included all individuals aged 19-64 years, living in Sweden on 31 December 2004, on 
DP due to CMD throughout 2005 (N= 48 803). Individuals with a history of schizophrenic 
spectrum (ICD 10: F20-F29) or bipolar disorder (ICD 10: F31) as main diagnosis at 
specialized outpatient or inpatient care (n=1656) during 2001-05 and/or on old-age pension 
during 2005 (n=402) were excluded. The final cohort thus comprised 46 745 individuals. 
This cohort was followed up for five years (2006-10). The associations of different socio-
demographics, previous healthcare use and medication with subsequent suicidal behavior 
(i.e., suicide attempt and suicide) were estimated. 
In study II, the same cohort as in study I was used, however, it was somewhat altered as more 
information was added. Particularly, individuals, treated for schizophrenic spectrum or 
bipolar disorders as secondary diagnoses at specialized outpatient or inpatient care during 
2001-05 (n=230) were also excluded. Thus, a cohort of 46 515 individuals was followed up 
for five years. The associations of different DP measures, namely main and secondary 
diagnoses, duration and grade of DP with subsequent suicidal behavior were assessed.  
In study III, all individuals living in Sweden and aged 19-64 years with incident DP due to 
CMD before (wave 1, 2005-06, N=25 435) or after (wave 2, 2009-10, N=4722) the 
introduction of stricter DP granting criteria in 2008 were included. The individuals who 
emigrated or died during the 3 years after granted DP and/or for whom information regarding 
socio-demographics were missing, were excluded (wave 1=1137 (4.5%), and wave 2=666 
(14.1%)), hence the final cohorts included 24 298 and 4056 individuals for wave 1 and wave 
2, respectively. Socio-demographically adjusted healthcare use trajectories (in- and 
specialized outpatient care due to mental or somatic diagnoses) during the three years before, 
the year during, and the three years after DP were assessed.  
In study IV, from 4722 individuals with incident DP due to CMD in 2009-10, 80 were 
excluded due to missing in amount of prescribed ADs in all six measured time points. 
Therefore, the study population included 4642 individuals. Trajectories of annual DDDs of 
ADs were analyzed over a 6-year period by a group-based trajectory method. Associations 
between socio-demographic and medical factors and different trajectories were estimated.  
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Table 5. Overview of the four studies.  
 Study I Study II Study III Study IV 
Aim To explore whether 
different socio-
demographic factors, 
healthcare use, and 
medication are 
associated with suicidal 
behaviour (suicide and 
suicide attempt) in 
individuals on DP due to 
CMD 
To examine (1) how 
different measures 
of DP (main and 
secondary diagnosis, 
duration and grade) 
were associated with 
subsequent suicidal 
behaviour (suicide 
attempt and suicide) in 
individuals on DP due to 
CMD and (2) possible 
differences in these 
associations with regard 
to sex and age 
To study (1) in- and 
specialized outpatient 
healthcare use 
trajectories before, 
during and after being 
granted DP due to 
CMD and  
(2) whether these 
trajectories differed 
before and after the  
introduction of stricter 
DP granting criteria in 
Sweden in 2008 
To (1) identify and 
describe different 
trajectories of ADs over 
a 6-year period (before, 
during and after DP) and 
(2) analyze the 
heterogeneity, if any, 
between the trajectories 
by socio-demographics 
and medical factors 
Design Prospective cohort study 
with baseline data on 31 
December 2004 and 
follow-up until 31 
December 2010 
Prospective cohort study 
with baseline data on 31 
December 2004 and 
follow-up until 31 
December 2010 
Cohort study with 
prospective and 
retrospective repeated 
measurements, baseline 
data on 31 December 
prior to DP granting 
year, observation for 7-
years   
Cohort study with 
prospective and 
retrospective repeated 
measurements, baseline 
data on 31 December 
prior to DP granting year 
(2008-09), observation 
for 6-years   
Study 
population; n 
46 745 (66.3% women; 
aged 19-64 at baseline) 
46 515 (66.4% women; 
aged 19-64 at baseline) 
24 298 (cohort 2005-
06; 69% women, aged 
19-64 at baseline); 
4056 (cohort 2009-10; 
63.5% women, aged 
19-64 at baseline) 
4642 (2009-10, 62.4% 
women, aged 19-64 at 
baseline)  
Inclusion 
criteria 
On 31 December 2004: 
alive, living in Sweden, 
aged 19-64, on DP due 
to CMD throughout 
2005, not treated due to 
schizophrenic spectrum 
or bipolar disorder (as 
main diagnosis) at 
specialized healthcare 
during 2001-05, not on 
old age pension during 
2005 
On 31 December 2004: 
alive, living in Sweden, 
aged 19-64, on DP due 
to CMD throughout 
2005, not treated due to 
schizophrenic spectrum 
or bipolar disorder (as 
main or secondary 
diagnosis) at specialized 
healthcare during 2001-
05, not on old age 
pension during 2005 
Incident DP due to 
CMD either during 
2005-06 or 2009-10, 
who did not emigrate or 
die during the 3 years 
following DP and did 
not have missing in the 
socio-demographics 
Incident DP due to 
CMD during 2009-10, 
not having missing 
regarding amount of 
prescribed ADs through 
observation period 
Data sources LISA
1, MiDAS2, 
National Patient 
Register, Prescribed 
Drug Register, Cause of 
Death Register 
LISA1, MiDAS2, 
National Patient 
Register, Cause of Death 
Register 
LISA1, MiDAS2, 
National Patient 
Register, Cause of 
Death Register 
LISA1, MiDAS2, 
National Patient 
Register, Prescribed 
Drug Register, Cause of 
Death Register 
Outcome 
measures  
Suicide attempt 
(n=1046, 2.2%) and 
suicide (n=210, 0.4%) 
Suicide attempt 
(n=1036, 2.2%) and 
suicide (n=207, 0.5%) 
Trajectories of in- and 
specialized outpatient 
healthcare use due to 
mental or somatic 
diagnoses 
Trajectories of ADs 
Factors 
included in the 
analyses 
Sex, age, educational 
level, type of living area, 
country of birth, family 
situation, previous 
suicide attempt, previous 
in- and specialized 
outpatient mental and 
somatic healthcare use 
and  previous and 
current (during the 
exposure year) 
prescribed 
antidepressants and 
anxiolytics 
Sex, age, educational 
level, type of living area, 
country of birth, family 
situation, previous 
suicide attempt, 
previous in- and 
specialized outpatient 
mental and somatic 
healthcare use, main and 
secondary DP 
diagnoses, duration and 
grade of DP  
Sex, age, educational 
level, type of living 
area, country of birth, 
family situation 
Sex, age, educational 
level, type of living area, 
country of birth, family 
situation, main DP 
diagnosis,  in- and 
specialized outpatient 
mental and somatic 
healthcare use 
Statistical 
analyses 
Descriptive, 
Chi2-test, 
Cox proportional 
hazards regression 
models, Survival curves 
Descriptive, 
Chi2-test, 
Cox proportional 
hazards regression 
models 
Descriptive, 
Chi2-test, 
Generalized Estimating 
Equations with 
autoregressive 
correlations 
Descriptive, 
Group-based trajectory 
modelling, 
Multinomial logistic 
regression, 
Chi2-test 
1LISA:  Longitudinal Integration Database for Health Insurance and Labour Market Studies; 
2MiDAS:  Micro Data for Analysis of the Social Insurance. 
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3.2 Data sources 
All four studies of the thesis were of the Insurance Medicine All Sweden (IMAS) project, 
including de-identified data obtained from nationwide registers maintained by Statistics 
Sweden (SCB), the National Board of Health and Welfare, and the Social Insurance Agency 
(SIA). The ten-digit unique personal identity numbers (PIN) attributed to all inhabitants of 
Sweden were used to link information from the different registers [249]. 
3.2.1 Longitudinal Integration Database for Health Insurance and 
Labour Market Studies (LISA) 
This register was initiated in 1990 and is updated annually since then by Statistics Sweden 
(SCB) [250]. LISA contains information on socio-demographics and social insurance 
measures of all individuals aging from 16 years and above and living in Sweden on 31 
December of a given year. LISA, in all four studies, was used in order to obtain socio-
demographic information at baseline, namely sex, age, educational level, country of birth, 
type of living area, family situation, date of emigration, and old-age pension. 
3.2.2 Micro Data for Analysis of the Social Insurance (MiDAS) 
The dataset ‘Micro Data for Analyses of Social Insurance (MiDAS)’ is maintained by the 
Social Insurance Agency (SIA). MiDAS contains detailed information on DP and SA benefits 
since 1994 [251]. Among others, information on main DP diagnoses (study I, II, III, and IV), 
secondary DP diagnoses (study II), start and end date of DP spell (study I, II, III & IV), extent 
of DP to determine grade as full-time or part-time and change of DP grade (study II) was 
used in the respective studies. MiDAS was used to define the study population in all four 
studies. 
3.2.3 The National Patient Register 
The National Patient Register, which is held by the National Board of Health and Welfare, 
contains data on inpatient care and specialized outpatient care [252]. This register was 
established in 1964, when data on inpatient care due to somatic disorders begun to be 
collected in six Swedish counties. From 1973, data on inpatient care due to mental diagnoses 
was included in this register. In 2001, it became compulsory to report specialized outpatient 
care visits. The inpatient care register is of good quality and covers almost ninety nine percent 
of all hospital admissions, whereas about eighty percent of specialized outpatient care is 
recorded in the outpatient care register [252, 253]. All diagnoses for in- or specialized 
outpatient care were determined according to the ICD-10 [214]. In all four studies, this 
register was used to obtain data on mental and somatic in- and specialized outpatient care, 
and suicide attempt from inpatient care. In study I and II, information on schizophrenic 
spectrum and bipolar disorders from in- and specialized outpatient care was used to exclude 
individuals from the cohort. The National Patient Register does not include information from 
primary healthcare. 
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3.2.4 The Prescribed Drug Register 
The Prescribed Drug Register, from the National Board of Health and Welfare, was 
established in July 2005 [254]. The register includes information for all prescribed and 
dispensed medication in Sweden [254]. The register contains information on date of 
prescription and dispensing of medication, generic and trade names, form of a prescribed 
medication (e.g., tablets, syrup, suspension, etc.), anatomical therapeutic chemical (ATC) 
codes, amount of dispensed medication per package, and DDDs per package [254, 255]. 
Information on antidepressants and anxiolytics obtained from this register was used in study I 
and IV. 
3.2.5 The Cause of Death Register 
This register is maintained by the National Board of Health and Welfare and was established 
in 1952 [256]. It records all deceased individuals, regardless of whether the death was inside 
Sweden or abroad and has about one percent of missing information of all deaths [213]. The 
causes of death are determined according to ICD-10 [213]. In study I and II, the Cause of 
Death Register was used to identify the outcome, suicide deaths; and to calculate person-time 
by censoring for death due to other causes than suicide. The date of death was used to 
exclude individuals during the follow-up in study III and to calculate DDDs during the death 
year and onward in IV. 
3.3 Exposure, covariates and outcome measures 
Socio-demographic factors, for all four studies, were measured at baseline, which is on 31 
December of the year preceding DP grant. Specialized healthcare use, for study I and II, was 
considered before and during the exposure year and medication for study I was considered 
during the year of exposure. In study III, specialized healthcare use was measured at seven 
different time points, whereas in study IV, medication was measured at six different time 
point.  
3.3.1 Socio-demographic factors 
The considered socio-demographic factors included in the studies were age, sex, level of 
education, country of birth, type of living area, and family situation. They were used as risk 
factors for study I. In studies II, III, and IV, socio-demographic characteristics were 
considered as covariates and all the analyses were controlled for such covariates. Besides 
controlling, they were also taken into account to determine significant sex (study I, II and IV) 
and age (study II) differences between the sub-groups. In study III, they were additionally 
used to identify the significant differences between the two cohorts that were granted DP 
before and after policy changes. In study IV, socio-demographics along with main DP 
diagnoses, were used to explain heterogeneity between the trajectory groups. 
In study I, reference categories for the different socio-demographic risk factors for 
subsequent suicidal behaviour were chosen as those groups with lower risk (based on 
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previous findings) or groups covering the majority of individuals in the study population. 
Age was categorized in years as follows: 19-24, 25-34, 35-44, 45-54, and 55-64 (reference). 
In study II, age was categorized as 19-44 years and 45-64 years (reference). Level of 
education was calculated in years and classified as compulsory (0-9), high school (10-12) and 
university (13 or more) (reference) in all four studies. 
Type of living area, which was determined by the population size of a given area of living, 
included big cities (e.g., Stockholm, Gothenberg and Malmo) (reference category), medium-
sized cities (with more than 90 000 inhabitants within 30 kilometre distance from the center) 
and small cities/ villages area [257]. Family situation was constructed from two variables 
from the LISA dataset, containing information regarding civil status and children (age and if 
living at the same place as the parents). This variable was classified into ‘married/cohabiting 
without children living at home’, ‘married/cohabiting with children living at home’ (reference 
group), ‘single (living without partner/divorced/separated/widowed) without children living 
at home’, ‘single (living without partner/divorced/separated/widowed) with children living at 
home’ and ‘adolescents living with parents, 16-20 years old’. The last category, except for 
study IV, was merged with the category ‘single (living without partner/divorced/separated/ 
widowed) without children living at home’ due to power issues. Country of birth was 
categorized into Sweden (reference in all studies), other Nordic countries, EU 25 without 
Nordic countries, and the rest of the world. The second and the third sub groups of country of 
birth were pooled together for statistical convenience in study III and IV. 
Eventual missing values of covariates were coded as separate categories (study I and II). 
3.3.2 Used measures of disability pension 
Different DP measures, namely, main (study II and IV) and secondary (study II) DP 
diagnosis, duration and grade (study II) of DP were considered as risk factors. All 
information on DP diagnoses was based on the corresponding codes of ICD-10 [214]. 
Information on the main and secondary DP diagnoses, which was recorded on the basis of 
corresponding ICD codes, was obtained from MiDAS. Main diagnoses were categorized as, 
‘depressive disorders’ (reference) including ‘depressive episode’ (F32) and ‘recurrent 
depressive disorder’ (F33); ‘anxiety disorders’ comprising ‘phobic anxiety disorder’ (F40); 
‘other anxiety disorder’ (F41); ‘obsessive–compulsive disorder’ (F42); and ‘stress-related 
mental disorders’ including ‘reaction to severe stress, adjustment disorders, acute stress 
reaction and posttraumatic stress disorder’ (F43) [153, 174]. Secondary diagnoses (study II) 
were categorized as: ‘no secondary diagnosis’ (reference); ‘substance abuse disorders’ (F10–
F19); ‘personality disorders’ (F60–F69); ‘other mental disorders’ (F00–F99 except F10–F19, 
F60–F69); ‘musculoskeletal disorders’ (M00–M99); and ‘other somatic disorders’ (all 
diagnoses except M00–M99 and F00–F99). Schizophrenic spectrum and bipolar disorders 
(i.e. individuals with these disorders were excluded in study I and II) were coded as follows: 
ICD-10 codes F20–F29 and F31. 
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DP duration was calculated by subtracting the start date of DP from the end date of exposure 
(31 December 2005) in gross days. Gross days of DP were considered as full days 
disregarding the extent, that is, duration of DP of an individual with a part-time DP for 365 
days would be recorded as 365 days, similarly as of another individual on fulltime DP for 365 
days. Thereafter, the days were converted into years and were categorized as ‘1 year’ 
(reference), ‘2–3 years’ or ‘≥4 years’. ‘DP grade in 2005’ was classified as ‘part-time’ 
(reference) and full-time. Full time was regarded as 100% and any other extent less than 
100% was included in the part-time sub-group. 
3.3.3 Suicide and suicide attempt 
In this PhD project, suicidal behaviour included both suicide attempt and completed suicide. 
Suicide attempts were identified from the inpatient care register and suicides from the cause 
of death register according to the ICD-10 codes. In order to limit underreporting and to 
compensate for regional and temporal variation in ascertainment methods, intentional self-
harm (ICD-10: X60-X84) and events of undetermined intent (ICD-10: Y10-Y34) were 
combined for the entire PhD project. Sensitivity analyses were carried out to ensure that the 
estimates for determined and undermined suicide were similar. Similar sensitivity analyses 
were also carried out with respect to suicide attempt also.  
In study I and II, suicide attempt and suicide were considered as outcome measures and 
contributed in calculating person-time, also inpatient care due to previous suicide attempt was 
considered as a risk factor in study I and as a covariate in study II. 
3.3.4 Healthcare and medication 
In this PhD project, healthcare related factors included in- and specialized outpatient care due 
to mental or somatic diagnoses and inpatient care due to suicide attempt. In study I and II, in- 
or specialized outpatient care due to mental or somatic diagnoses, and inpatient care due to 
suicide attempt before or during the exposure year were taken into consideration. For study 
III, similar healthcare use (except for inpatient care due to suicide attempt) during pre- and 
post-DP period was analyzed to understand the trends of such healthcare-related factors. 
Study IV included in- and specialized outpatient care due mental or somatic diagnoses before 
granted DP. 
Information on in- and specialized outpatient care due to mental or somatic diagnoses was 
regarded as risk factors for study I, covariates for study II and was additionally used to 
describe the differences between the identified AD trajectory groups in study IV. In study III, 
information on such healthcare use was measured annually for 7-years of observation, 
including the pre-DP, transition, and post-DP periods. Such information was retrived from 
the National Patient register. Information on specialized healthcare use was measured as total 
number of individuals having had such care during the studied years (yes/no) in all four 
conducted studies. Regarding the main diagnoses of healthcare use, those who had code F00-
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F99 (ICD-10) were categorized as mental and all others as somatic diagnoses. Inpatient care 
due to suicide attempt included the following ICD-10 codes: X60-84 and Y10-34.  
In addition to the specialized healthcare factors, prescribed dispensed psychiatric medication, 
determined by respective ATC codes [255], particularly antidepressants (N06A) and 
anxiolytics (N06B) were used as risk factors in study I. In study IV, trajectories of prescribed 
ADs (N06A) were studied at six time points, during the pre- and post-DP period. In study I, 
all considered psychiatric medications were categorized as ‘yes’ and ‘no’ and was coded as 
‘yes’ if the medication was prescribed at least once during the exposure year. Amount of 
ADs, for study IV, was calculated based on the prescribed amount of DDDs of the prescribed 
AD. 
3.4 Statistical analyses 
In this PhD project, the study cohort included individuals either on prevalent (study I and II) 
or with incident DP (study III and IV) due to CMD. In all four studies, descriptive statistics, 
including frequencies, percentages, means with standard deviations, and medians of 
covariates were calculated. In studies I, II, and IV, descriptive statistics were presented with 
sex stratification. Potential sex (studies I, II, and IV) and age (study II) differences in these 
factors were assessed by chi2-test. Differences between socio-demographics with regard to 
year of granted DP were tested in study III using the same method.  
In order to analyse the associations of different socio-demographic and medical factors 
(including healthcare and medication) (study I), along with DP measures (study II) with 
subsequent suicidal behaviour (suicide attempt and suicide) in individuals with prevalent DP 
due to CMD throughout 2005, Cox proportional hazards regression models were applied with 
crude and adjusted hazard ratios (HR) and 95% confidence intervals (CI). Proportional 
hazard assumptions were tested prior to the application of these models. The partial 
likelihood ratio test was used to test for possible interactions with sex (study I and II), and 
age (study II). The proportions of suicide attempts during follow-up were estimated by life 
tables and plotted in 1-survival curves for previous suicide attempt and medication, stratified 
by sex (study I). 
In study I and II, individuals were followed up until the event (suicide attempt, death due to 
suicide), death (due to other reasons than suicide), emigration, or end of follow-up which ever 
came first. In both these studies, follow-up time started after the exposure year (2005), on 01-
01-2006 and ended 31-12-2010. In addition to crude/univariate models, multivariate HRs 
were estimated where all the factors were mutually adjusted for in study I and II.  
In study III, analyses were based on annual diagnosis-specific specialized healthcare use, 
namely in- and specialized outpatient care due to mental or somatic diagnoses, with a 7-year 
observation window for each individual with incident DP due to CMD granted either during 
2005-2006 or 2009-2010. The year of DP granting was defined as time point ‘t0’ and the 
three years of observation for both before and after the t0 year comprised t-3 to t-1 and t+1 to 
t+3, respectively. Individuals, granted DP during 2005-2006 and 2009-2010, comprised wave 
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1 and wave 2, respectively. Initially, the between-wave differences in socio-demographics 
and annual prevalence of healthcare use were assessed by Chi2 test. In order to adjust for 
between-wave variations with regard to socio-demographics, estimated annual prevalence 
rates of healthcare use with 95% CI were assessed during the three years before, the DP 
granting year, and the three years after DP. Hereby, repeated measure logistic regression 
analyses with a Generalized Estimating Equations (GEE) method and autoregressive (AR) 
correlation structure were used [258].  
GEE is a repeated measure regression, which takes the interdependence between the repeated 
intra-individual measurements into account by assigning correlations between measurements 
in longitudinal studies. An autoregressive correlation (AR) structure assumes the correlation 
between time points to be greater the nearer the measurements are to each other. Therefore, 
we used AR based on the assumption that the correlation of healthcare use is stronger 
between time points that are closer to each other in time. Estimated annual prevalence and 
odds ratios (OR) with 95% CI of healthcare use at different time points (from t-3 to t+3) 
between the waves (wave 1 and 2) were compared. Significant between- and within-wave 
differences in the trend of healthcare use (in- and specialized outpatient care due to mental 
and somatic diagnoses) by introducing interaction terms between period (pre-DP: t −3 to t−1; 
transition: t −1 to t+1; and post-DP: t +1 to t+3) and wave (wave 1 and wave 2) in the model. 
The chosen statistical method provides a flexible approach to analyses of longitudinal data by 
accounting for correlations between outcomes across time within the same individual and 
allowing for specification of both time-varying effects and individual differences in variables. 
Moreover, GEE does not depend on the normal distribution of the data and can incorporate 
subjects in the models even if they have missing values on the dependent variable. All models 
were adjusted for sex, age, education, type of living area, country of birth, and family 
situation. Individuals with missing values in the socio-demographic factors were excluded 
from the GEE models. Sensitivity analyses indicated the comparability of results in the study 
populations with and without exclusion due to missing values. 
In study IV, group-based trajectory modelling was used to estimate trajectories of ADs 
among individuals with incident DP due to CMD during 2009-2010, for each person at six 
time points (i.e. within a six-year window, starting from three years before and ending at 
three years after the date of being granted DP). For this purpose, annual purchases of ADs in 
DDDs were calculated for the six studied years, considering the date of granted DP; t0. There 
were 194 annual purchases exceeding 1500 annual cumulative DDDs (around 4 DDDs per 
day). This was assessed as an unusually high dosage and therefore DDDs were truncated at a 
level of 1500. Such high amounts of ADs might have been due to special cases, i.e., need of 
large purchases before traveling abroad, or error in data. Group-based trajectory models 
estimate 1) changes in AD patterns over time in multiple subgroups within the cohort, 2) a 
regression model for each discrete group and 3) assess proportions of individuals in each 
group. Additionally, this flexible model allows for different polynomials of the outcome 
[259]. The Bayesian information criterion (BIC) was used to test the best-fitted model related 
to the number of groups between 2-8. While six and seven group models had better BIC 
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values compared to the five-group model, there were very few individuals in some of the 
groups. Therefore, the model with five groups was considered to be most appropriate. 
Probabilities for an individual to be assigned to a specific trajectory group were calculated. 
The highest estimated probability was used to decide each individual’s group belonging.  
Thereafter, the association of covariates in each AD trajectory group were estimated by chi2-
test and multinomial logistic regression. Moreover, likelihood ratio tests were used to 
evaluate whether socio-demographic and medical factors (main DP diagnosis, in- and 
specialized outpatient care due to mental or somatic diagnoses) were associated with type of 
trajectory group in the full model. Additionally, Nagelkerke pseudo R2 values were estimated 
to evaluate the strength of these associations. By consecutively excluding and re-including 
each factor from the full model, we calculated differences in R2 for each factor in order to 
examine the contribution of a given factor to the full model. In case of death or emigration 
during the study period, due to differences in the exposure time, annual DDD was considered 
missing for the event year and onwards. 
Analyses were performed using statistical software SPSS version 20.0 (study I), version 22.0 
(study II, study III and study IV), and SAS for Windows version 9.4 (study IV) (SAS-based 
procedure “Traj” [260]). 
 
 37 
4 Results 
The results of the four studies are presented below.  
4.1 Study I 
In total in Sweden, there were 46 745 individuals on DP due to CMD during 2005. Out of 
these, 17 181 (36.8%) were on DP due to depressive episode, 11 022 (23.6%) had a diagnosis 
of reaction to severe stress and adjustment disorders, 9799 (21.0%) due to other anxiety 
disorders, 4950 (10.6%) due to a recurrent depressive disorder, 2783 (5.9%) received DP due 
to phobic anxiety disorder and 1010 (2.2%) because of an obsessive-compulsive disorder. 
The majority (66.3%) were women, 38.7% were aged 55-64 years, nearly half (47%) had 
been to high school, most lived in big or medium sized cities (74%), and 3 out of 4 were born 
in Sweden. Almost half of the study population (41.9%) was living without a partner and 
without children at home. Furthermore, in the five years preceding start of follow-up (2001-
05), only 28% had had specialized outpatient care and 11% inpatient care due to mental 
diagnoses. Around 33% were hospitalized due to somatic diagnoses and three percent of the 
cohort had been treated for attempted suicide (2001-05). While approximately one third of 
the disability pensioners were prescribed only ADs during the exposure year (2005), 16% 
were prescribed and dispensed both antidepressants and anxiolytics.  
In the cohort, 1046 (2.2%) individuals attempted and 210 (0.4%) committed suicide during 
the five-year follow-up (2006-10). Women were more likely than men to attempt suicide 
(women: 2.4%, men: 2.0%), while a higher proportion of men completed suicide (women: 
0.3%, men: 0.7%). Mean follow-up time for suicide attempt and suicide was around 5 years 
(4.85 (standard deviation (SD) 0.70) and 4.91 (SD 0.52), respectively. 
Table 6 shows, that female sex, younger age, low education, and living without partner and 
with or without children were associated with a higher risk for suicide attempt (range of HRs 
1.15 to 2.11) compared to men, age over 55 years, high education, and living with a partner 
and children, respectively. Additionally, previous in- and specialized outpatient healthcare 
use due to mental diagnoses (range of HRs 1.30 to 2.88), previous inpatient care due to 
suicide attempt (HR 3.89; 95% CI: 3.29-4.60) compared to those without similar healthcare 
use was strongly associated with a higher risk for subsequent suicide attempt. Moreover, 
prescribed medication in 2005, especially antidepressants and anxiolytics in combination (HR 
3.35; 95% CI: 2.83-3.98) was associated with subsequent suicide attempt compared to no 
medication.  
Statistically significant interactions were observed between sex and inpatient care due to 
previous suicide attempt in 2001-05 (p=0.009) and prescribed medication (p=0.004) in 2005. 
Women with previous inpatient care for suicide attempt had a higher risk for subsequently 
attempting suicide (HR 4.43; 95% CI: 3.63- 5.41) compared to women without such care. 
The comparable HR for men was 2.75; 95% CI: 1.99-3.79. With regard to prescribed 
dispensed antidepressants and anxiolytics together, the HR for attempting suicide for women 
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was 3.96; 95% CI: 3.19-4.92 and for men 2.48; 95% CI: 1.86-3.31 compared to individuals 
with no such medication during the follow-up. 
Multivariate HRs and 95% CI for suicide indicated that male sex and living without partner 
and without children was associated with a higher risk for suicide (range of HRs 1.68 to 2.14) 
compared to female sex and living with partner and children. Previous inpatient care due to 
mental diagnoses or suicide attempt as well as medication, namely anxiolytics alone or in 
combination with antidepressants, were still strongly associated with completed suicide 
(range of HRs 2.1 to 3.3) compared to individuals without such inpatient care or medication. 
Table 6. Multivariate hazard ratios (HRs) with 95% confidence interval (CI) for suicide 
attempt and suicide (2006-10) among 46 745 women and men, aged 19-64 years and living in 
Sweden on 31 December 2004, on DP due to CMD throughout 2005. 
Characteristics Suicide attempt Suicide 
n (%) HRs (95% CI) n (%) HRs (95% CI) 
Sex 
 Men 310 (2.0) 1 108 (0.7) 2.14 (1.61-2.85) 
 Women 736 (2.4) 1.15 (1.01-1.32) 102 (0.3) 1 
Age (years) in 2005 
 19-24 61 (7.2) 2.11 (1.55–2.89)  9 (1.1) 1.23 (0.59-2.60) 
 25-34 161 (4.8) 2.06 (1.64–2.59)  28 (0.8) 1.32 (0.82-2.14) 
 35-44 342 (3.5) 2.06 (1.69–2.52)  40 (0.4) 0.90 (0.58-1.39) 
 45-54 306 (2.1) 1.52 (1.25–1.85)  74 (0.5) 1.26 (0.88-1.81) 
 55-64  176 (1.0) 1 59 (0.3) 1 
Educational level (years)  
 Compulsory (0-9) 347 (2.9) 1.57 (1.29–1.91) 63 (0.5) 0.90 (0.62-1.32) 
 High school (10-12) 540 (2.5) 1.38 (1.15–1.65)  95 (0.4) 0.80 (0.57-1.12) 
 University (13 or >) 152 (1.2) 1 50 (0.4) 1 
 Unknown 7 (1.4) 0.86 (0.40-1.85)  2 (0.4) 0.80 (0.19-3.33) 
Family situation 
 Married/cohabit. with no children at home 88 (0.9) 0.73 (0.56-0.95)  29 (0.3) 1.23 (0.72-2.10) 
 Married/cohabit. with children at home 201 (1.9) 1 30 (0.3) 1 
 Single1 no children at home  558 (2.8) 1.23 (1.04-1.45)  125 (0.6) 1.68 (1.11-2.53) 
 Single1 with children at home 199 (3.1) 1.29 (1.06-1.57) 25 (0.4) 1.48 (0.86-2.54) 
Diagnosis-specific specialized outpatient care in 2001-05 (ref. no diagnosis-specific outpatient care) 
 Somatic diagnosis  872 (2.5) 1.12 (0.94-1.33) 164 (0.5) 0.95 (0.67-1.35) 
 Mental diagnosis  571 (4.4) 1.30 (1.14-1.48) 103 (0.8) 1.23 (0.91-1.66) 
Diagnosis-specific inpatient care in 2001-05 (ref. no diagnosis-specific inpatient care) 
 Somatic diagnosis  613 (3.9) 1.45 (1.26-1.67) 107 (0.7) 1.29 (0.94-1.76) 
 Mental diagnosis  507 (10) 2.88 (2.47-3.35) 90 (1.8) 2.71 (1.94-3.80) 
 Suicide attempt  314 (22.0) 3.89 (3.29-4.60) 46 (3.2) 3.00 (2.00-4.50) 
Prescribed medication dispensed in 2005 (ref. no medication) 
 Antidepressants only 299 (2.2) 1.82 (1.52-2.17) 47 (0.3) 1.32 (0.89-1.96) 
 Anxiolytics only 109 (3.2) 2.24 (1.77-2.82) 23 (0.7) 2.10 (1.28-3.44) 
 Both  prescribed  423 (5.8) 3.35 (2.83-3.98) 86 (1.2) 3.30 (2.31-4.72) 
1single includes living without partner, divorced, separated or widowed  
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 4.2 Study II 
Of the 46 515 individuals on DP due to CMD during 2005, the majority (66.4%) were 
women and 70% were aged between 45-64 years. As main DP diagnosis, nearly half of the 
women (48.3%) and older individuals (51.5%) had depressive disorders, while 32% of men 
and 43% of the younger individuals had anxiety disorders. The two predominant main DP 
diagnoses for the entire cohort were ‘depressive episode’ (36.8%) and ‘stress-related mental 
disorder’ (23.6%). More than half of the cohort had a secondary DP diagnosis (56.9%). More 
men and older individuals had substance abuse disorders as a secondary diagnosis, while 
more women and younger individuals had comorbid personality disorders (p<0.001). The 
majority of the individuals had full-time DP (75.6%). Part-time DP was more common 
among women (28%) than men (17.4%) and among older (26.7%) than younger individuals 
(19.2%) (p<0.001). Regarding the covariates, nearly half (47%) of the study population had 
been to upper-secondary education, most lived in big or medium sized cities (74%), and 75% 
were born in Sweden. Almost half of them (42%) lived without a partner and without 
children. 
In the cohort, 1036 (2.2%) individuals were treated in inpatient care due to suicide attempt 
and 207 (0.5%) committed suicide during the five-year follow-up (2006-10). Women were 
somewhat more likely than men to attempt suicide (women: 2.4%, men: 2.0%, p<0.01) while 
a higher proportion of men completed suicide (women: 0.3%, men: 0.7%. p<0.001). Mean 
follow-up time for suicide attempt and suicide was 4.85 (SD: 0.70) and 4.91 (SD: 0.52) years, 
respectively. 
In the univariate analyses, anxiety disorders were associated with a higher risk for subsequent 
suicide attempt in both women and men (range of HRs 1.4 to 1.5) and suicide in the younger 
age group (HR 1.9; 95% CI: 1.1-3.3) compared to depressive disorders as main diagnoses. 
These associations became insignificant after controlling for socio-demographics in the 
multivariate models, except for suicide in individuals aged 19-44 years (HR 1.7; 95% CI: 
1.0-3.0) (Table 7 and 8). In general, stress-related mental disorders (SRMD) as main DP 
diagnosis, compared to depressive disorders, were associated with a lower risk for future 
suicide attempt and suicide in both crude and multivariate adjusted models. There was a 
significant interaction between age and main diagnosis (p=0.017) regarding suicide. 
Individuals aged 45-64 years with a main DP diagnosis of SRMD had a significantly lower 
risk for committing suicide during the follow-up compared to individuals with a depressive 
disorder as main DP diagnosis (HR 0.4; 95% CI: 0.2-0.6). This association was not observed 
in younger individuals. 
In the univariate models, secondary DP diagnoses of mental origin were associated with a 
higher risk for subsequent suicide attempt in all subgroups (range of HRs 1.2 to 7.1). These 
associations remained significant (range of HRs 1.3 to 2.3) in the multivariate models, except 
for the group of other mental disorders as secondary diagnoses in men and in the older age 
group. Comorbid substance abuse and personality disorders increased the risk for suicide 
(range of HRs 1.9 to 9.6) in women and in both age groups in the crude analyses compared to 
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their counterparts without a secondary diagnosis. However, in the adjusted model, only 
substance abuse disorders predicted suicide among women and younger individuals (range of 
HRs 2.6 to 3.3). A statistically significant interaction between sex and secondary diagnoses 
(p=0.029) in relation to subsequent suicide was found. Women with substance abuse 
disorders as secondary DP diagnoses were at a higher risk for subsequent suicide compared to 
women without a secondary diagnosis. Such associations were not observed among men. 
DP duration did not predict suicidal behaviour in the adjusted models. On the other hand, 
full-time DP in the univariate analyses was associated with a higher risk for suicidal 
behaviour in all sex and age subgroups (range of HRs 1.3 to 3.1) compared to individuals on 
part-time DP. After multivariate adjustment, these associations remained significant (range of 
HRs 1.4 to 1.7) for suicide attempt in women and both age groups, and for suicide among the 
older individuals. A statistically significant interaction was observed between sex and DP 
grade (p=0.001) in relation to subsequent suicide attempt. Women on full-time DP had a 
higher risk for future suicide attempt compared to women who were on part-time DP. No 
such association was found for men. 
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Table 7. Multivariate hazard ratios (HR) with 95% confidence interval (CI) for suicide attempt and suicide (in 2006-2010), in the 46 515 individuals, aged 
19-64 years, living in Sweden on 31 December 2004, and on disability pension (DP) due to common mental disorders in 2005, stratified by sex. 
Characteristics Suicide attempt Suicide 
Women Men Women Men 
n % HR (95% CI) n % HR (95% CI) n % HR (95%CI) n % HR (95% CI) 
Main DP diagnosis 
  Depressive disorders 355 34.3 1 139 13.4 1 53 25.6 1 50 24.2 1 
  Anxiety disorders 278 26.8 1.0 (0.9-1.2) 140 13.5 1.0 (0.8-1.2) 32 15.5 0.9 (0.6-1.4) 47 22.7 1.3 (0.8-2.0) 
  Stress-related mental disorders 99 9.6 0.8 (0.6-1.0) 25 2.4 0.6 (0.4-0.9) 17 8.2 0.9 (0.5-1.6) 8 3.9 0.4 (0.2-0.9) 
Secondary DP diagnosis 
  No secondary diagnosis 232 22.4 1 100 9.7 1 34 16.4 1 45 21.7 1 
  Substance abuse disorders 43  4.2 2.1 (1.5-2.9) 34 3.3 1.6 (1.0-2.4) 9  4.3 3.3 (1.5-7.1)   7 3.4 0.8 (0.3-1.7) 
  Personality disorders 83  8.0 1.4 (1.1-1.8) 39 3.8 1.4 (1.0-2.1) 12  5.8 1.8 (0.9-3.5) 9 4.4 0.9 (0.4-1.8) 
  Other mental disorders 253 24.4 1.3 (1.1-1.5) 95 9.2 1.2 (0.9-1.6) 27 13.0 1.1 (0.6-1.8) 29 14.0 0.9 (0.6-1.5) 
  Musculoskeletal disorders 56 5.4 1.1 (0.8-1.5) 10 1.0 0.7 (0.4-1.4) <7 2.9 0.8 (0.3-2.0) <7 2.4 0.7 (0.3-1.9) 
  Other somatic disorders 65 6.3 1.1 (0.9-1.5) 26 2.5 1.0 (0.7-1.6) 14 6.8 1.6 (0.9-3.0) 10 4.8 0.8 (0.4-1.7) 
Number of years on DP in 2005 
  1 year 100 13.7 1 42 13.8 1 13 12.7 1 14 13.3 1 
  2-3 years 308 42.1 0.9 (0.7-1.1) 137 45.1 1.0 (0.7-1.4) 46 45.1 1.0 (0.5-1.8) 51 48.6 1.0 (0.6-1.8) 
  ≥4 years 324 44.3 1.0 (0.8-1.2) 125 41.1 0.9 (0.6-1.3) 43 42.2 1.0 (0.5-1.8) 40 38.1 0.7 (0.4-1.3) 
DP grade 
  Part-time 84 8.1 1 42 4.1 1 16 7.7 1 10 4.8 1 
  Full-time 648 62.8 1.7 (1.4-2.2) 262 25.4 0.9 (0.6-1.3) 86 41.6 1.5 (0.8-2.6) 95 45.9 1.7 (0.9-3.3) 
Adjusted for: sex, educational level, family situation, country of birth, type of living area, previous suicide attempt, inpatient care due to mental diagnoses, specialized outpatient care due to mental diagnoses. 
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Table 8. Multivariate hazard ratios (HR) with 95% confidence interval (CI) for suicide attempt and suicide (2006-2010), in 46 515 individuals, aged 19-
64 years and living in Sweden on 31 December 2004, and on disability pension (DP) due to common mental disorders in 2005, stratified by age. 
Characteristics Suicide attempt Suicide 
Age 19-44 years Age 45-64 years Age 19-44 years Age 45-64 years 
n % HR (95% CI) n % HR (95% CI) n % HR (95% CI) n % HR (95% CI) 
Main DP diagnosis 
  Depressive disorders 217 21.0 1 277 26.7 1 20 9.7 1 83 43.0 1 
  Anxiety disorders 278 26.8 1.1 (0.9-1.3) 140 13.5 0.9 (0.8-1.2) 44 21.3 1.7 (1.0-3.0) 35 16.9 0.9 (0.6-1.3) 
  Stress-related mental disorders 62 6.0 0.8 (0.6-1.1) 62 6.0 0.7 (0.5-0.9) 12 5.8 1.7 (0.8-3.6) 13 6.3 0.4 (0.2-0.8) 
Secondary DP diagnosis 
  No secondary diagnosis 140 13.5 1 192 18.5 1 20 9.7 1 59 28.5 1 
  Substance abuse disorders 40 3.9 2.3 (1.6-3.3) 37 3.6 1.5 (1.1-2.2) 8 3.9 2.6 (1.1-6.1)  8 3.9 1.0 (0.5-2.3) 
  Personality disorders 85 8.2 1.5 (1.1-2.0)  37 3.6 1.6 (1.1-2.2) 13 6.3 1.7 (0.8-3.4) 8 3.9 1.1 (0.5-2.3) 
  Other mental disorders 233 22.5 1.5 (1.2-1.9)  115 11.1 1.0 (0.8-1.3) 30 14.5 1.3 (0.8-2.4) 27 13.0 0.8 (0.5-1.3) 
  Musculoskeletal disorders 23 2.2 1.1 (0.7-1.8) 43  4.2 0.9 (0.7-1.3) <7 1.9 1.7 (0.6-4.9) 7 3.4 0.6 (0.3-1.3) 
  Other somatic disorders 36 3.5 1.2 (0.8-1.8) 55 5.3 1.1 (0.8-1.4) <7 1.0 0.5 (0.1-2.1) 22 10.6 1.3 (0.8-2.2) 
Number of years on DP in 2005 
  1 year 95 17.1 1 47 9.8 1 7 9.2 1 20 15.3 1 
  2-3 years 254 45.6 0.8 (0.7-1.1) 191 39.9 1.0 (0.7-1.3) 39 51.3 1.8 (0.8-4.0) 58 44.3 0.7 (0.4-1.2) 
  ≥4 years 208 37.3 0.9 (0.7-1.4) 241 50.3 1.0 (0.7-1.4) 30 39.5 1.7 (0.7-3.8) 53 40.5 0.6 (0.3-0.9) 
DP grade 
  Part-time 56 5.4 1 70 6.8 1 7 3.4 1 19 9.2 1 
  Full-time 501 48.6 1.4 (1.1-1.9)  409 39.6 1.5 (1.1-1.9) 69 33.3 1.3 (0.6-3.0) 112 54.1 1.7 (1.0-2.8) 
Adjusted for: sex, educational level, family situation, country of birth, type of area of living, previous suicide attempt, inpatient care due to mental diagnoses, specialized outpatient care due to mental diagnoses 
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4.3 Study III 
There were 24 298 and 4056 individuals granted DP due to CMD in 2005-2006 (wave 1) and 
2009-2010 (wave 2), respectively. In both waves, more than two-thirds were women, 
whereas, the proportion of young individuals (19-29 years) was more than three times higher 
in wave 2 than in wave 1 (18.3% vs. 5.4%). The proportion of singles without children living 
at home was also higher in wave 2 (48.1%) compared to those in wave 1 (37.4%). Moreover, 
there were more individuals born outside the Nordic countries and EU 25 in wave 2 (18.0%) 
than in wave 1 (14.9%).  
The proportion of individuals with mental healthcare use was generally significantly higher in 
wave 2 than in wave 1 (p-values <0.001). In the year preceding DP, 4.6% and 19.2% of 
individuals had had mental in- and specialized outpatient care, respectively, in wave 1, 
compared to 7.9% and 46.6% in wave 2. Stratified analyses for the similar time points 
showed that corresponding figures in younger individuals (19-29 years of age) were 11.8% 
and 38.4% in wave 1 and 14.3% and 65.1% in wave 2; and for the older individuals (30-64 
years of age) 4.1% and 18.2% in wave 1 and 6.5% and 42.5% in wave 2.  
Multivariate adjusted prevalence rates of inpatient healthcare use due to mental diagnoses 
were higher in the year preceding DP and lower thereafter in both waves (Figure 6). 
Compared to the year of granting DP (reference: OR=1), odds ratios (ORs) of inpatient care 
due to mental diagnoses in wave 1 increased from 0.8 to 1.2 (t-3 to t-1) and later decreased to 
0.8 at t+3 (figure 7). There was a significant between-wave difference of these trajectories in 
the transition period, showing a steeper decline in wave 2 (p<0.05)2.  
Multivariate adjusted trajectories of specialized outpatient care due to mental diagnoses 
followed similar patterns as those of mental inpatient care, with exception of an increasing 
trend after being granted DP in wave 1 (Figure 6 and 7). There were significant between-
wave differences in trajectories of specialized mental outpatient care at all three phases (pre-, 
transition, and post-DP) (p<0.05)3.  
In accordance with mental healthcare use, specialized care due to somatic diagnoses was 
significantly more common in wave 2 than in wave 1 (p-values <0.001). In wave 1, annual 
prevalence rates corresponded to 9.1% and 40.3% of somatic in- and specialized outpatient 
care, respectively. The corresponding figures for wave 2 were 13.6% and 50.6%. There were 
no clear within-wave trends in somatic healthcare use observable in the pre-, transition, and 
post-DP periods. Still, slopes differed significantly in the transition period between waves 
due to a relatively stronger decline in wave 2 than in wave 1 (p<0.05)4. 
                                                 
2 Please see supplementary table in the appendix 
3 Please see supplementary table in the appendix 
4 Please see supplementary table in the appendix 
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Figure 6. Estimated prevalence rates of diagnosis-specific specialized healthcare use adjusted for sex, age, education, type of living area, country of birth, 
and family situation, at different time points# before and after being granted disability pension (DP) due to common mental disorders in the two studied 
waves* (error bars indicate 95% confidence intervals). 
 
* wave 1- DP granted during 2005-2006 (before); wave 2- DP granted during 2009-2010 (after the introduction of stricter DP rules) 
 # t-3: 3 years before DP, t-2: 2 years before DP, t-1: 1 years before DP, t-0: year of DP grant, t+1: 1 years after DP, t+2: 2 years after DP, t+3: 3 years after DP  
0.03
0.04
0.05
0.06
0.07
0.08
0.09
t-3 t-2 t-1 t0 t+1 t+2 t+3
E
st
im
at
ed
 p
re
v
al
en
ce
Inpatient healthcare due to mental diagnoses
wave 1 wave 2(after)
0.09
0.19
0.29
0.39
0.49
0.59
t-3 t-2 t-1 t0 t+1 t+2 t+3E
st
im
at
ed
 p
re
v
al
en
ce
Specialized outpatient healthcare due to 
mental diagnoses
wave 1 wave 2 (after)
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
t-3 t-2 t-1 t0 t+1 t+2 t+3
E
st
im
at
ed
 p
re
v
al
en
ce
Inpatient healthcare due to somatic diagnoses
wave 1 wave 2 (after)
0.00
0.00
0.00
0.00
0.00
0.01
0.01
t-3 t-2 t-1 t0 t+1 t+2 t+3
E
st
im
at
ed
 p
re
v
al
en
ce
Specialized outpatient healthcare due to 
somatic diagnoses
wave 1 wave 2 (after)
 45 
Figure 7. Odds ratios (OR) of healthcare use adjusted for sex, age, education, type of living area, country of birth, and family situation at different time 
points# compared to disability pension (DP) granting year (t0) before and after being granted DP in the two studied waves* (error bars indicate 95% 
confidence intervals). 
 
* wave 1- DP granted during 2005-2006 (before); wave 2- DP granted during 2009-2010 (after the introduction of stricter DP rules)  
 # t-3: 3 years before DP, t-2: 2 years before DP, t-1: 1 years before DP, t-0: year of DP grant (reference, OR=1), t+1: 1 years after DP, t+2: 2 years after DP, t+3: 3 years after DP 
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4.4 Study IV 
The study population for study IV included 4642 individuals, who were granted DP due to 
CMD in 2009-10 in Sweden. Two thirds of the cohort were women (62.4%) and 77.3% were 
born in Sweden. When granted DP, most of them were aged 45-64 years (57.8%), had 
proceeded to high school education (46.0%), lived in big cities (39.9%), and were single 
without any child living at home (45.3%). A higher proportion of the women (14.5%) than of 
the men (3.3%) were single with children living at home. Depressive disorders comprised the 
most common (46.3%) main DP diagnosis. A history of specialized outpatient healthcare use 
due to mental and somatic diagnoses was more common than such inpatient care (57.6%, 
74.0% compared to 16.7%, 29.1%, respectively). 
Figure 8 shows the estimated five groups of different trajectories of DDDs of ADs. The 
groups were labelled as, ‘low constant’, ‘low increasing’, ‘middle constant’, ‘high constant’, 
and ‘high increasing’. Many of the individuals (‘low constant’ 33.5% of the cohort) had none 
or very low (less than 50) annual DDDs of ADs. Nearly six percent (‘low increasing’) had 
very low annual DDDs three years before DP granting, and showed a steep increase in annual 
DDDs of ADs up to 785 at two years following DP. The group ‘middle constant’ (33.7%) 
had annual DDDs in between 200-300 during the study period. The ‘high constant’ group 
included 20.8% of the cohort, and had 500-600 DDDs per year throughout the study period. 
In the groups ‘middle constant’ and ‘high constant’, there was a slight decline in DDDs of 
ADs following the DP. Six percent of the cohort increased from approximately 800 DDDs 
three years before DP granting and levelled off at around 1100 DDDs per year in the years 
after DP granting until the end of follow-up (high increasing).  
All socio-demographic and medical factors, but sex and previous healthcare use due to 
somatic diagnoses, were significantly associated with different trajectory groups (p<0.05) in 
the unadjusted analyses. In the full model, along with other variables, sex was significantly 
associated with the trajectory groups. The full model explained 17.2% of the variance 
between the groups (using Nagelkerke pseudo R2). The highest estimated difference of five 
percent was observed for ‘previous mental outpatient care’ (diff. in R2=0.05), otherwise the 
individual factors, other than age (diff. in R2=0.021) and main DP diagnosis (diff. in 
R2=0.015), merely effected the full model independently. 
All the groups had a larger proportion of older individuals (>50%, 45-64 years), except for 
the ‘low increasing', where younger individuals constituted the absolute majority (>60%, 19-
44 years), and notably 41.3% of those in this group were in the 19-24 age range. This group 
also had fewer individuals (17.3%) who have been to university compared to the other 
groups, whereas the ‘high increasing’ group had the highest proportions of individuals having 
attended high school or university (53% and 29.6%, respectively). In the ‘low increasing’ 
group, 80% of the individuals were single and did not have any children living at home. 
Other socio-demographic factors were fairly equally distributed among all five groups. 
 
 47 
 
Figure 8. Trajectory groups of antidepressants according to annual defined daily doses (DDDs) and percentages of individuals with disability pension 
(DP) due to common mental disorders in 2009-2010 (N=4642) within each trajectory group. The dotted lines represent 95% confidence intervals. 
* t0 was calculated as the average of t-1 and t+1 for the graphical presentation 
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Regarding the main DP diagnosis, the ‘low increasing’ group had equal proportions of 
depressive and anxiety disorders (43% each), whereas in all other trajectory groups, 
depressive disorders dominated (40-54%). The percentage of the individuals with ‘stress-
related mental disorders’ as main DP diagnosis was largest in the ‘low constant’ (31.5%) and 
‘middle constant’ (21%) groups. The proportions of the individuals from the ‘high 
increasing’ group who had had previous in- or specialized outpatient care due to mental 
diagnoses were approximately twice as high compared to the proportions of the ‘low 
constant’ group (24%, 79.4% and 9.1%, 40.5%, respectively). 
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5 Discussion 
5.1 Main findings 
In these nationwide prospective cohort studies of people on DP due to CMD, female sex, 
younger age, low educational level, living without a partner, previous specialized healthcare 
use due to mental or somatic diagnoses, previous suicide attempt, as well as previous 
prescribed psychiatric medication (both antidepressants and anxiolytics alone or combined) 
were associated with a higher risk of subsequent suicide attempt. While, male sex, living 
without partner and no children living at home, previous inpatient care due to mental 
diagnoses or suicide attempt along with concomitant prescription of antidepressants and 
anxiolytics were predictive of completed suicide. 
Risk of suicidal behaviour was also found to be related to the type of DP diagnoses and DP 
grade. Stress-related mental disorders as the main DP diagnoses were associated with a lower 
risk of subsequent suicidal behaviour compared to depressive disorders as main DP 
diagnoses. Moreover, comorbid substance abuse disorders and personality disorders, as well 
as full-time DP were associated with a higher risk of suicide attempt and suicide during 
follow-up. Some sex and age differences in these associations emerged. 
After (wave 2) implementation of stricter DP granting regulations in 2008 in Sweden, 
incidence of DP due to CMD was almost six times lower than in before (wave 1). On the 
other hand, proportions of individuals who had used specialized healthcare were higher in 
wave 2 than in wave 1 (in the year preceding DP, wave 2: inpatient care 7.9%; specialized 
outpatient care 46.6%; wave 1: inpatient care 4.6%; specialized outpatient care 19.2%). 
Moreover, it was found that in both waves inpatient mental healthcare use increased before 
granted DP, after which it decreased. With regard to trajectories after granted DP, there were 
differences between the two waves. While outpatient mental healthcare use declined in wave 
2 (from 43.5% at DP granting year to 32.8% at two years following DP), it continued to 
increase in wave 1 (from 22.7% at DP granting year to 26.8% at two years following DP). 
Trajectories of specialized somatic healthcare use did not follow any obvious pattern.  
According to the annual DDDs of ADs, five trajectory groups were identified over a 7-year 
period among all 4642 individuals granted DP due to CMD during 2009-2010. For the vast 
majority of individuals (89%), namely for low-, middle- and high constant groups, DDDs of 
ADs – though on different levels – varied only slightly before and after granting of a DP. In 
the low- and middle constant groups (67% of the cohort), about a third of the individuals, 
who more often had stress-related DP diagnoses and less healthcare due to mental diagnoses, 
received very low levels or no AD during the years around the time of DP grant. Two smaller 
groups (6% each) showed increases of DDDs up to granting of the DP, in one group DDDs 
levelled off afterwards and in the other group they kept increasing. Individuals in this latter 
group tended to be younger and were more likely to have an anxiety disorder as a DP 
diagnosis. 
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5.2 Discussion of results 
5.2.1 Suicidal behaviour following disability pension 
Increased mortality including suicide among disability pensioners, especially among those 
granted DP due to mental diagnoses has been shown previously [24, 120, 121, 127, 128, 138, 
141]. In study I, the aim was to identify risk factors for suicidal behaviour in individuals with 
DP due to CMD. The study identified that women were at a higher risk for suicide attempt 
and men for suicide. These findings are in line with studies in the general population, 
providing well-established results on sex differences regarding suicidal behaviour [25, 221, 
261, 262]. Moreover, younger age and low education were associated with a higher risk of 
suicide attempt, which is also in line with previous research [133, 199, 261, 263]. Results also 
suggest that living without a partner and without children increased the risk of suicidal 
behaviour in this cohort. Similar results from studies on the general population [261] and on 
disability pensioners [263] have been reported. In contrast, living with a partner but without 
children seemed to have a protective influence with regard to suicide attempt compared to 
those who are living with a partner and with children. These risk and protective indicators 
should be taken into consideration when monitoring mental health of disability pensioners 
due to CMD.  
Previous and ongoing in- and specialized outpatient care due to mental diagnoses and 
previous suicide attempt turned out to be the strongest predictors for subsequent suicidal 
behaviour. This is in line with findings from previously conducted studies on suicidal 
behaviour in the general population [132, 133] and among psychiatric patients from in- and 
outpatient care [25, 198, 264]. Additionally, a statistically significant interaction between sex 
and inpatient care due to previous suicide attempt was observed. Women with previous 
inpatient care for suicide attempt had a higher risk for future suicide attempts compared to 
women without such care (HR 4.43; 95% CI: 3.63–5.41). In men, this association was found 
to be not as strong as in women (HR 2.75; 95% CI: 1.99–3.79). It should be noted that suicide 
attempts were found to be more common among women than men in several European 
countries, except for Finland [193, 202, 204], and suicide attempt is in itself a strong risk 
factor for subsequent suicide attempt in the general population or in individuals with 
depression [202, 265].  
In this cohort, an association between inpatient care due to somatic diagnoses and future 
suicide attempt was observed. Previous research suggests that somatic disorders, for instance, 
cancer, stroke, epilepsy, multiple sclerosis, and different other neurological disorders are 
associated with an increased risk of suicidal behaviour [261, 266]. Such associations might be 
due to chronic pain or the terminal nature of the disease. This observed association was 
independent from the effect of mental disorders treated in in- or specialized outpatient care 
and prescribed psychiatric medication. Still, these measures might not entirely cover 
underlying mental disorders and residual confounding is likely. 
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Our results also suggest that disability pensioners with prescribed solitary anxiolytics, or in 
combination with antidepressants, had a higher risk of suicidal behavior than those without 
any such prescription. Moreover, statistically significant interactions were found between sex 
and prescribed psychiatric medication for subsequent risk of suicide attempt. ADs are 
recommended for treatment of depression and anxiety disorders [160, 267-270]. Additionally, 
anxiolytics, particularly benzodiazepines, can be prescribed for acute conditions or for 
individuals with predominant sleep disorders [160, 269, 270]. It is known that comorbid 
anxiety may worsen the prognosis and may pose an increased risk for suicidal behaviour in 
patients with depressive disorder [131, 182, 271, 272]. Additionally, an association of 
benzodiazepines with increased suicidal behaviour have previously been reported [273-275]. 
Future studies are warranted in order to understand the association of type, frequency, and 
dosage of prescribed anxiolytics and subsequent suicidal behaviour in disability pensioners 
due to CMD. 
Study II have explored the risk of suicidal behaviour related to DP diagnoses, duration, and 
grade. Such risk, related to a main DP diagnosis of anxiety disorders did not differ from that 
of depressive disorders, while those with ‘stress-related mental disorders’ as main DP 
diagnoses had a lower risk for future suicidal behaviour. This is in line with a recent study on 
diagnosis-specific SA, suggesting higher risk estimates for subsequent suicide among people 
on SA due to depressive and anxiety disorders than due to stress-related mental disorders, 
after adjustment for socio-demographic factors and morbidity [130]. A potential reason for 
this is that the reported lower risk of suicidal behaviour can be interpreted as lower levels of 
morbidity in individuals receiving a stress-related diagnosis when work disabled compared to 
individuals receiving a depressive or anxiety disorder as main DP diagnosis [276].  
There was a significant interaction with age and main DP diagnoses in relation to suicide. 
While there was a significantly lower risk for suicide in the older age group (45-64 years) 
with a main DP diagnosis of ‘stress-related mental disorders’ compared to ‘depressive 
disorders’, this association was not found in the younger individuals. On the other hand, 
‘anxiety disorders’ as main diagnoses were associated with a higher risk of subsequent 
suicide in the individuals aged 19-44 years, compared to the similar age group with a main 
DP diagnosis as ‘depressive disorders’. One likely explanation of such findings includes age 
differences in the association of mental disorders with suicide risk [133, 231]. Anxiety 
disorders often have an early onset, and younger individuals may tend to have higher 
impulsivity, which might have contributed to suicidal behavior [277]. Moreover, early onset 
anxiety disorders leading to DP might be more difficult to treat and probably are associated 
with a high degree of comorbidity [278, 279]. Adequate treatment and suicide risk 
assessments might be of particular importance in young individuals with DP due to anxiety 
disorders in order to prevent suicidal behaviour [163, 233].   
Furthermore, findings show that having a mental secondary DP diagnosis was associated with 
a higher risk of suicide attempt and suicide compared to not having a secondary diagnosis in 
individuals on DP due to CMD. This is in line with previous research regarding the general 
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population [133, 135] and individuals with a diagnosed mental disorder [131, 134, 136]. 
Substance abuse and personality disorders were the strongest predictors of subsequent suicide 
attempt. A high risk of suicidal behaviour among individuals with substance abuse disorders 
has previously been reported [132, 135, 236]. A significant interaction was observed between 
sex and substance abuse as secondary DP diagnosis in relation to subsequent suicide. Women 
with ‘substance abuse disorders’ as the secondary DP diagnosis were at a higher risk of 
subsequent suicide compared with women without a secondary diagnosis (HR 3.3; CI: 1.5 to 
7.1). In contrast, a secondary DP diagnosis did not seem to be associated with an elevated risk 
of subsequent suicide in men. Substance abuse might be less prevalent and less frequently 
diagnosed in women compared to in men. Therefore, it can be hypothesized that women who 
are diagnosed with such a DP diagnosis form a selection of cases with particular medical 
severity, which in turn might be the reason for their higher suicide risk [132, 133, 236]. It is 
also possible that health consequences of substance abuse disorders might be worse in 
women compared to men [280]. Moreover, substance abuse disorders may aggravate an 
existing comorbid depression, which itself is a risk factor for suicidal behaviour [280-283]. 
Comorbid personality disorder was strongly associated with a higher risk of suicide attempt 
compared to those who did not have any secondary DP diagnosis. Current literature suggests 
that personality disorder, comorbid with depression or by itself, involves a higher risk of 
suicide attempt [177, 238]. Therefore, monitoring of individuals with such comorbidities is of 
particular importance in order to prevent suicidal behaviour. 
Full-time DP was associated with a higher risk of suicidal behaviour compared to part-time 
DP. This has not been reported before in disability pensioners but is in line with a previous 
study reporting a higher risk of suicidal behaviour concerning full-time compared to part-time 
SA [263]. Full-time DP might here be associated with a higher severity of the underlying 
disorder. On the other hand, full-time DP might also be related to an alteration in health 
behaviour (regarding alcohol consumption, smoking, physical activity, diet, etc.) or to social 
isolation due to the loss of working colleagues [140-142] . More knowledge is warranted on 
the mechanisms behind these associations [141]. 
A statistically significant interaction was observed between sex and DP grade, women with 
full-time DP had a higher risk for subsequent suicide attempt than women with part-time DP 
(HR 1.7; CI: 1.4-2-2). Such higher risk was not found in men on fulltime DP compared to the 
men on part-time DP (HR 0.9; CI: 0.6 to 1.3). In Sweden, the proportion of women on part-
time DP tends to be much higher compared to men  [284]. It might be anticipated that if 
women are granted full-time DP then they might have a higher severity of the underlying 
mental disorder and, therefore, they might have a higher risk of subsequent suicide attempt 
[263].  
5.2.2 Healthcare use trajectories 
Considerable differences regarding incidence of DP before and after changes in the DP 
granting criteria in 2008 were found. Incidence of DP due to CMD was almost six times 
higher before the policy changes (incidence in 2005-06, wave 1) than after (incidence in 
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2009-10, wave 2). A similar decline in all-cause DP incidence, around the time of the 
introduction of stricter DP granting criteria in 2008 has previously been reported [3].  
Our results show that trajectories of mental in- and specialized outpatient healthcare use 
followed a similar pattern in both waves in the pre-DP period, namely a steep increase up 
until the year prior to DP granting. This is in line with previous studies showing an increase 
in prescription of psychiatric medication, suicide attempts as well as in self-reported 
symptoms of depression and anxiety just before granted DP [30-33, 285]. The patterns of 
between-wave differences were consistent also when adjusted for socio-demographic factors 
such as sex, age, education, type of living area, country of birth, and family situation. Such 
increase in healthcare use might be related to a worsening medical condition just before DP 
granting, which in fact might have led to applying for DP. It could be also due to needing 
assessments from specialists when claiming DP. 
The results also indicated that in general, use of specialized mental healthcare decreased after 
being granted DP due to CMD. This resembles findings from similar recent research on 
prescribed psychiatric medication, suicide attempts and reported symptoms of depression and 
anxiety [30, 31, 33, 285, 286]. The decline may be related to improvements in symptoms 
and/or relief from psychosocial work demands. It might also be that, improvements in 
symptoms occurred as individuals did not have to worry any longer if the physician will 
certify a prolongation of the sick-leave spell, or if the Social Insurance Agency will accept the 
sickness-benefit claim. With regard to trajectories after granted DP, there were differences 
between the two waves. While outpatient mental healthcare use declined in wave 2, it 
continued to increase in wave 1. Reasons for such dissimilarities might arise from differences 
in wave 1 and wave 2 with regard to rehabilitation processes before granted DP, the medical 
severity of individuals granted DP, and specificities in the regulations. In wave 1 it was still 
possible to be granted temporary DP when between 30 and 64 years of age. It is possible that 
DP did not have a strong influence on specialized mental outpatient care in individuals from 
wave 1 with temporary DP, possibly due to a lower medical severity of the underlying 
disorder compared to individuals granted DP in wave 2. Future research is warranted to 
elucidate this potential explanation. 
The results showed that the annual prevalence of in- and specialized outpatient care use due 
to mental diagnoses was considerably higher among individuals granted DP in 2009-2010 
(wave 2) than in 2005-2006 (wave 1), and the same was true for somatic healthcare use. 
Specifically, in terms of specialized outpatient healthcare use due to mental diagnoses prior to 
DP, a much higher proportion of individuals from wave 2 (27-47%) had used such healthcare 
before being granted DP than their peers from wave 1 (8-19%). Such differences in 
healthcare use may point to a worse medical condition of the individuals granted DP with the 
stricter criteria in 2009-2010 compared to those granted DP in 2005-2006.  
Nevertheless, although a larger proportion had received specialized care before being granted 
DP in wave 2, still less than 50% had used such healthcare, meaning that the majority of the 
individuals did not receive specialized healthcare for mental diagnoses a year prior to DP due 
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to CMD. This finding is in line with findings from Norwegian and Finish studies [105, 106], 
indicating inadequate mental healthcare before granted DP. Adequate healthcare before DP 
might prevent a number of people from premature exclusion from the labour market. It is 
therefore important to provide suitable treatment and rehabilitation options for individuals 
with CMD in the pre-DP period, as these disorders are reported to be treatable and likely to 
relapse or worsen otherwise [103, 104].  
Specialized healthcare use seems to decline in general immediately after granted DP, with 
further stabilization. However, if such frequency of specialized healthcare use during the 
post-DP period is optimal still remains a question, and requires adequate attention for further 
research. In a former study among men on DP from Sweden, Wallman et al. reported that, 
though the frequency of healthcare use decreased among DP men in the post-DP period 
compared to pre-DP, still it was higher compared to their peers who received old age pension 
(OAP) or who were still at work [109]. Similar pattern of trajectories in the post-DP period 
was also reported regarding amount of purchased psychiatric drugs [30-32], self-reported 
symptoms of depression and anxiety [33], or even regarding risk of suicide attempt in young 
adults [285]. Such a decline might have been due to a relief from work demands. Adequate 
healthcare should of course also be assured after the DP granting to prevent a poor prognosis.  
Not only mental healthcare use, but also somatic healthcare use was considerably more 
prevalent among individuals in wave 2 compared to in wave 1. The trajectories of specialized 
somatic healthcare use were relatively stable throughout the study period. This is the first 
study investigating trajectories of specialized somatic healthcare use in relation to DP 
granting due to CMD. Study II shows that around 24% of individuals on DP due to CMD had 
somatic comorbidity. It is likely that these somatic comorbid disorders are of a chronic 
nature, requiring regular somatic healthcare use and might therefore be not directly affected 
by or related to the timing of DP granting. Additionally, to control for the possible 
discrepancies in access to healthcare between different regions of Sweden, we controlled for 
living area, which was categorized according to the size of the population. 
5.2.3 Trajectories of prescribed antidepressants 
The five identified trajectory groups were heterogeneous regarding levels of dispensed 
amounts of ADs. A third of the individuals in the study population, the ‘low constant’ group, 
either had very low or no annual DDDs of ADs during the six years of observation. This 
group of individuals had stress-related DP diagnoses more often and less healthcare use due 
to mental diagnoses. This might give an indication that these individuals have had a lower 
medical severity. They might also have received some other forms of treatment like 
psychotherapy instead of ADs. Information on psychotherapy was unfortunately not available 
in this study. Additionally, in acute situation or due to other comorbidity some might have 
received other forms of psychiatric drugs, i.e. anxiolytics or sedatives, there were around ten 
percent of such individuals in the study cohort. One should also consider the adherence to 
prescribed dispensed medication, since possibilities of not taking the prescribed dispensed 
medication cannot be excluded [287]. Still, this study focused on the indication and amount 
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of a prescribed dispensed medication rather than its efficacy. Therefore, non-adherence does 
not seem to be a considerable limitation of this study. 
A relatively smaller group, ‘low increasing’, was similar to the ‘low constant’ group in terms 
of amount of ADs during the first two years of the observation period, but with a further steep 
increase thereafter up until two years following granted DP. Nearly half of the individuals in 
this group were aged 18-24 years and unlike the other trajectory groups, anxiety disorders 
contributed similarly as depressive disorders for granting of DP in this group. Depressive 
disorders were the most common DP diagnoses in all the trajectory groups. Such prevalence 
of anxiety disorders in this group might be due to the fact that many of them were young and 
anxiety disorders usually have an earlier onset [154, 288, 289].  
Previous mental inpatient or specialized outpatient healthcare use was proportionate to the 
amount of ADs, i.e., the highest AD purchases were found in the ‘high constant group’ and 
the lowest in the ‘low constant’ group. A greater proportion of individuals from the ‘low 
increasing’ group was treated at in- or specialized outpatient care for both mental and somatic 
diagnoses than other groups. Based on these facts, it seems that individuals from the ‘low 
increasing’ group might have suffered from severe mental disorders several years before 
granted DP, and that the disorders worsened with time leading to DP.   
One should also consider that individuals might still have received adequate dosages of AD 
and subsequently improved clinically, but not regarding their work capacity [166, 173, 290]. 
The findings show that most trajectory groups had relatively stable annual DDDs of ADs 
around the time when granted DP. This is in contrast to findings from a Finnish project, 
where prescription of ADs substantially increased before and decreased immediately after 
granted DP, especially among those with a mental DP diagnosis [30, 31]. These discrepancies 
in findings might arise from the differences in DP diagnoses, i.e. in our study the focus was 
on CMD, while most other previous studies included all mental disorders. Differences in the 
DP granting system between Sweden and Finland may also contribute in this regard. 
Additionally, it should also be considered that this cohort is a very special one, as it is the 
immediate cohort following a policy change. Still, this study is internationally the first study 
considering groups of trajectories and not only one trajectory common for all individuals with 
DP. Therefore, this study highlights the importance of elucidating the heterogeneity in 
treatment patterns before and after granting of DP. One group differed considerably from the 
patterns of the other trajectory groups, i.e., the ‘low increasing’ group which showed a steep 
increase in DDDs of ADs since the beginning of the study period (t-3) up to DP granting and 
continued to increase after that.  
The study findings also indicate heterogeneity regarding socio-demographics and medical 
factors between the trajectory groups. Among the socio-demographic variables, age had the 
strongest association with trajectory groups in the full model. There were also observable 
differences in educational level and family situation between the trajectory groups. For 
instance, unlike other groups, only a small proportion of individuals from the ‘low constant’ 
group had university education and the majority was single. Differences in educational level 
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or in the family situation in the ‘low increasing’ trajectory group might have been due to the 
younger age distribution in that group.  
Overall, 20-60% of the individuals, depending on the trajectory group, did not receive any 
specialized mental healthcare during the three years prior to DP. This is not in accordance 
with the Swedish sick-leave guidelines [291], stating that all patients on SA due to depression 
for more than six months, should be referred to a specialist. This may indicate that these 
individuals might have not received optimal treatment during the pre-DP years, leading to 
further worsening of work capacity and later resulting in exclusion from the labour market by 
being granted DP [105-107]. 
5.3 Discussion of methods 
Main strengths of the four studies are that they were all population-based, prospective in 
nature, including microdata of a very large number of factors either for each of the studied 
years or at an even more detailed level, derived from high quality Swedish nationwide 
registers [223, 253, 292-294]. Moreover, as we could include the whole working age 
population in Sweden, of the first two studies had enough power in relation to rare outcomes 
like suicide attempt or suicide. There were also no dropouts or loss to follow-up during the 
studies. Additionally, the studies were conducted with several years of follow-up, and the 
covariates were derived from different registers of different sources. 
Below is a brief discussion on different methodical aspects including limitations of the 
studies. 
Validity of diagnoses and coverage of information: In all four studies, cohorts were 
defined as all individuals on DP due to CMD. For the first two studies, the cohorts included 
prevalent DP cases and the latter two included incident DP cases for particular years. The 
ICD-10 codes, F32-33 and F40-43 were used to define CMD. The codes for underlying DP 
diagnoses were derived from the MiDAS register. The validity of the diagnoses of SA and 
DP is often discussed. A study from 1991, comparing sick-leave diagnoses with diagnoses 
from medical records, showed high validity of sick-leave diagnoses [294]. Moreover, DP 
diagnoses are set by the treating and certifying physician through thorough assessments of the 
patients’ disease, functioning, and work incapacity. As DP benefits are often paid for several 
years, granting of DP in most cases is preceded by long-term SA and is granted after a long 
process of medical evaluation and work capacity assessments [3]. Furthermore, the stigma 
around mental diagnoses [295, 296] lets us assume that a mental diagnosis is given as a main 
DP diagnosis only when the patient actually has a mental disorder and when the main reason 
of work incapacity cannot be contributed to a somatic diagnosis [297]. On the other hand, this 
implies that some people with CMD might not have been given CMD as the main DP 
diagnosis on the DP certificate. Thus, they would not be included in this study. This can also 
be seen as a strength, as our cohort of individuals with DP due to CMD is more strictly 
defined, or as a limitation as we do not know if the effect size would be bigger when 
including them. 
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The national patient register and the cause of death register have been used in all four studies. 
The first one has been validated by Ludvigsson et al., in 2011, which states that more than 
99% of all somatic and mental hospital discharges are registered in the national inpatient 
register [253]. According to this study, the positive predictive value of the diagnoses that are 
registered in the national inpatient register is 85-95%. Nevertheless, since the start of this 
register, primary diagnoses are missing in around three percent of all mental healthcare [253]. 
A point to note is, that there are indications of regional differences with regard to the 
specialized outpatient care services reporting information on diagnoses and treatment to the 
National Board of Health and Welfare during the first years of reporting [298]. This might 
have led to an underestimation during the years before DP granting for the cohort with 
incident DP during 2005-2006 in study III. Still, there is no reason to anticipate that this 
considerably affected the trajectories reported in this study. The cause of death register has, 
according to the report from the National Board of Health and Welfare, only about one 
percent missing, indicating good quality [213]. Moreover, Allebeck et al. in 1991, concluded 
that the causes of death regarding injury related death in young age are recorded with high 
accuracy [211]. The quality of the Swedish drug register, which was used in study I and IV, 
has been found to be good by Wettermark et al., in 2007 [254, 299]. A limitation of using the 
drug registers is, that we have no information on whether the individual actually used the 
dispensed medication.  
Internal and external validity: Selection bias, information bias and confounding are the 
main factors that can reduce the internal validity by introducing systematic or random errors 
[300]. 
Selection bias refers to the fact when a sample, which is selected from a population, does not 
represent the population, meaning that selection of the sample is not adequately randomized 
[300]. Fortunately, all four studies were population-based resulting in the fact that all 
individuals from all over Sweden who were eligible were included, and not a sample from the 
population. Therefore, the possibility of selection bias is minimal.  
Information bias includes misclassification, which can occur in the case of exposure or 
outcome measurements [300]. If the misclassification of exposure differs with regard to the 
outcome measure, then there occurs differential misclassification; whereas if such 
misclassification is not related to the outcome (random misclassification) then it is regarded 
as non-differential misclassification. A common way to introduce a differential 
misclassification is via recall bias, which should not to be an issue here as all the studies are 
based on high quality nationwide Swedish registers. However, a question may arise regarding 
combining suicide attempt and suicide with determined and undetermined intent for study I 
and II where underreporting or misclassification may occur. In order to compensate for 
underreporting of suicidal behaviour in study I and II, determined and undetermined suicide 
attempt and suicide have been combined. Sensitivity analyses were carried out to ensure that 
the estimates for determined and undermined suicide were similar. Similar analyses were 
conducted with respect to suicide attempt.  
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A confounding factor is associated with the exposure and the outcome and must not be an 
intermediate step in the causal path between the exposure and the outcome [300]. 
Considering the confounders while calculating the estimates for the association between 
exposure and outcome shall lead to more accuracy. A wide range of potential confounders 
including socio-demographic and medical factors were taken into account in all four 
conducted studies. Socio-demographics included age, sex, education, type of living area, 
family situation and country of birth. Among the medical factors, in- and specialized 
outpatient care due to mental or somatic diagnoses, inpatient care due to suicide attempt, 
prescriptions of antidepressants and anxiolytics were considered. Still, residual confounding 
is not unlikely. I could use data only from the specialized outpatient care and inpatient care, 
but did not have the possibility of using data from primary care and data on health complaints 
not leading to any healthcare. This means that it was not possible to control for the visits to 
primary care and for health complaints without healthcare, thus missing a part of the picture 
of the morbidity. Likewise, information about the individuals treated elsewhere than in 
inpatient care due to suicide attempt, and the attempts that were managed outside the 
healthcare settings was not available. Additionally, data on health behaviour such as smoking, 
alcohol consumption or physical activity as potential confounders was not available [133, 
301].  
In study I, information of prescribed antidepressants and anxiolytics was included. In this 
study, individuals with prescription of antidepressants and/or anxiolytics were compared to 
individuals without any such prescription in relation to suicide attempt and suicide, so 
confounding by indication is likely. The individuals with and without prescriptions are 
inherently different, since those with prescriptions have an indication or reason for such 
prescription. Therefore, prescription may also indicate a higher current medical severity of 
the underlying CMD in these prevalent DP cases, which thus results in a higher risk for 
suicidal behaviour.  
External validity is the extent to which results of a study can be generalized, from a sample to 
the general population, or from one population to another. All studies in this thesis included 
the whole working age population on DP due to CMD in Sweden, i.e., not a sample. 
Therefore, the question of external validity regarding general population in Sweden does not 
arise in this thesis. Additionally, results from these studies can be generalized to other 
countries, with similar healthcare and social insurance systems, e.g. other Nordic countries. 
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5.4 Conclusions 
 In this thesis, the following factors were found to be associated with higher risk of 
suicidal behaviour following granting of DP due to CMD:  
- for suicide attempt: female sex, younger age, low education, living single, previous use 
of in- and specialized outpatient healthcare due to mental diagnoses and previous 
inpatient care due to suicide attempt. 
- for suicide: male sex and living single without children, previous inpatient care due to 
mental diagnoses or suicide attempt as well as medication, namely anxiolytics alone or in 
combination with antidepressants. 
Risk factors for suicidal behaviour among individuals on DP due to CMD seem to be 
similar to the known risk factors for suicidal behaviour in the general population.  
 This thesis revealed that different measures of DP, i.e., depressive and anxiety disorders 
as main DP diagnosis, mental co-morbidity (particularly substance abuse and personality 
disorders), and fulltime extent of DP play a role when attempting to identify individuals 
with a higher risk of suicidal behaviour after being granted DP due to CMD.  
 Young adults (19-44 years of age) on DP due to anxiety disorders were found to have a 
higher risk for subsequent suicide. Particular attention should therefore be given to this 
group.  
 A remarkable decrease in the incidence of DP due to CMD was observed between the 
cohorts granted DP before and after the introduction of stricter DP granting regulations 
in 2008 in Sweden. Such difference might be related to the fact that a higher threshold of 
disease severity was set for DP granting after the changes in DP regulations.  
 The low frequency of specialized mental healthcare use in the year before being granted 
DP due to CMD indicates the importance of treatment awareness during the pre-DP 
period to minimise possible suboptimal treatment.  
 The identified five trajectory groups based on annual amounts of prescribed dispensed 
ADs among individuals granted DP due to CMD were heterogeneous regarding main DP 
diagnoses, age, and the severity of the mental diagnosis.  
 The fact that more than one third of the individuals who were granted DP due to CMD in 
2009-2010 were prescribed either very low dose or no ADs during the pre-DP period 
indicates a possibility of suboptimal pharmacological treatment before DP granting. 
Additionally, the marginal variation in the levels of prescribed dispensed ADs among the 
majority of the individuals between pre- and post-DP periods suggests that granting of 
DP does not affect the amount of prescribed ADs. 
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5.5 Further research  
Research on DP is still very limited. Among the existing literature, the majority of studies 
have focused on risk factors for being granted DP rather than potential outcomes of being on 
DP. More research on the post-DP period including investigations of health and social 
outcomes is therefore warranted. Changes of DP granting regulations have been carried out in 
some European countries. Therefore, future research should also focus on if such regulatory 
changes are associated with future health and social outcomes of individuals on DP. 
In this thesis, associations between different socio-demographics, medical factors, DP 
measured in different ways and suicidal behaviour after being granted DP were found. The 
studies carried out in this thesis project were the first of its kind, analysing health outcomes 
among individuals on DP due to CMD. It would therefore be important to conduct similar 
studies in order to find out if the findings can be replicated.  
The follow-up period used here regarding suicidal behaviour was five years and observation 
periods for the healthcare use and AD trajectories comprised seven and six years, 
respectively. Future studies with longer follow-ups are required to ensure good statistical 
power in measuring associations with rare outcomes like suicidal behaviour.  
The studies in this thesis could not include information on the severity of the DP diagnosis. 
Further research, including such information may help to be more precise with regard to the 
risk of suicidal behaviour subsequent to DP, and to better explain the trajectories of 
healthcare use and amount of prescribed dispensed ADs. Including information from primary 
healthcare use, for instance regarding comorbidity might also contribute in this regard. 
In this thesis, prescriptions of antidepressants and anxiolytics were taken into account. 
Considering information on all types of treatment modalities for CMDs in future studies, e.g., 
information on other treatments such as psychotherapy, might help to understand if 
individuals on DP due to CMD receive optimal pharmacotherapy. 
The cohorts used in the studies included individuals on DP due to CMD. Further studies 
considering and comparing more specific DP diagnostic groups, e.g., specific depressive and 
anxiety disorders would help to obtain more detailed knowledge and might have more 
clinical relevance. 
The incidence of DP due to CMD was found to be four fold higher in 2005-2006 than in 
2009-2010, between which, in 2008, a major reform in the DP regulations took place in 
Sweden. Further analyses including age-period-cohort analyses may shed light on possible 
differences in the incidence of DP granted during different years, specifically before and after 
changes in the DP granting regulations.  
This thesis was based on register data. Future research could favorably include information 
regarding medication intake, self-rated health, multi-morbidity, social connectedness, work 
environment, life style factors such as smoking, alcohol consumption, physical activity, as 
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well as different types of treatment and rehabilitation measures, work adjustments, etc. 
Inclusion of these factors may supplement the register data and better explain the health-
related and social aspects of being granted DP. 
The studies included information on main and secondary DP diagnoses defined by ICD-10 
diagnostic codes at a three-digit level. Access to such information at four- or five-digit level 
for all DP diagnoses would help in future studies to be more precise in defining the study 
population and subsequently detecting different effects. 
Studies of this thesis identified risk factors of future suicidal behaviour in individuals with DP 
due to CMD. The intent to single out the effect of DP from the effect of the underlying 
medical disorder on potential outcomes of being on DP is challenging. In the future, research 
methods should be developed to disentangle the effect of DP per se from the effect of the 
underlying disorder on health-related and social consequences of being on DP. 
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Appendix: 
Supplementary table for paper III. Odds ratios (OR) of trends in healthcare use+ among individuals aged 19-64 years, living in Sweden, and granted disability pension 
(DP) in 2005-06 (n=24298) or in 2009-10 (n=4056) due to common mental disorders within the pre-, transition and post-DP period by type of healthcare and DP 
granting year*. 
Outcome measures 
in relation to 
different DP 
granting periods 
Pre-DP period 
(Year t-1 vs t-3^) 
OR (95% CI) 
Effect 
modification 
χ2 (p-value) 
df#=1 
DP transition period 
(Year t+1 vs t-1^) 
OR (95% CI) 
Effect 
modification 
χ2 (p-value) 
df#=1 
Post-DP period 
(Year t+3 vs t+1^) 
OR (95% CI) 
Effect 
modification 
χ2 (p-value) 
df#=1 
Inpatient healthcare use due to mental diagnoses 
wave 1 1.48 (1.35 - 1.61) 0.95 (0.33) 0.72 (0.67 - 0.79) 5.21 (0.02) 0.93 (0.85 - 1.01) 0.00 (0.99) 
wave 2 1.35 (1.15 - 1.58)  0.59 (0.50 - 0.69)  0.92 (0.77 - 1.11)  
Specialized outpatient healthcare use due to mental diagnoses 
wave 1 2.88 (2.74 - 3.02) 6.26 (0.01) 1.44 (1.39 - 1.49) 434.29 (<0.01) 1.03 (1.00 - 1.07) 48.63 (<0.01) 
wave 2 2.55 (2.35 – 2.76)  0.60 (0.56 - 0.65)  0.78 (0.73 - 0.84)  
Inpatient healthcare use due to somatic diagnoses 
wave 1 0.96 (0.91 - 1.02) 3.24 (0.07) 1.02 (0.96 - 1.08) 3.98 (0.05) 1.10 (1.04 - 1.17) 3.83 (0.05) 
wave 2 1.09 (0.96 - 1.23)  0.89 (0.79 - 1.00)  0.97 (0.86 - 1.09)  
Specialized outpatient healthcare use due to somatic diagnoses 
wave 1 1.16 (1.12 - 1.20) 1.04 (0.31) 0.99 (0.95 - 1.02) 4.96 (0.03) 1.15 (1.11 - 1.18) 1.08 (0.30) 
wave 2 1.21 (1.12 - 1.31)  0.90 (0.83 - 0.97)  1.10 (1.02 – 1.18)  
+Adjusted for sex, age, education, type of living area, country of birth, family situation; * wave 1- DP granted during 2005-06; wave 2- DP granted during 2009-10; # df- degree of freedom; ^ reference 
